Lisa A. Cannon-Albright

Lisa A. Cannon-Albright, PhD

Languages spoken: English

Academic Information

Departments Primary - Internal Medicine

Divisions: Epidemiology

Dr. Lisa Cannon-Albright is Professor and Division Chief of the Division of Genetic Epidemiology in the Department of Medicine at the University of Utah School of Medicine. She is a Huntsman Cancer Institute investigator and a member of the Cancer Control and Population Sciences program. As a Genetic Epidemiologist her research interests include computerized genealogy data, high risk pedigree studies, and predisposition gene identification.

Dr. Albright has over 3 decades of experience in designing and directing studies of high-risk pedigrees to identify genes predisposing to cancer and other diseases. Genes identified in Utah high risk pedigree studies include NF (Barker et al.); Alport Syndrome (Atkins et al): BRCA1 (Miki et al, 1994); BRCA2 (Tavtigian et al, 1996); p16 (Kamb et al, 1994; Cannon-Albright et al., 1994); and ELAC2/PRCA2 (Tavtigian et al., 2001). Dr. Albright's research goals are to identify and understand predisposition genes for common traits. Her research group accomplishes this primarily through analysis of genealogy data and the study of extended Utah high-risk pedigrees. She currently directs and is involved in cancer studies of prostate cancer, pancreas cancer, Ewings sarcoma, melanoma, pelvic floor disorders, colorectal cancer, and the exploration of new population-based resources. Her work is sponsored by the National Institutes of Health, the University of Utah, AACR, Alex's Lemonade Stand, the Huntsman Cancer Institute, and the George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah.

Dr. Albright has over 3 decades of experience analyzing a unique computerized genealogy of Utah, linked to medical data, to describe the heritable contribution to various health-related phenotypes including cancer, influenza mortality, asthma mortality, aneurysm, heart disease, diabetes, and rotator disease (Cannon et al., 1982, Cannon-Albright et al., 1994; 2003; 2005, Horne et al., 2005, 2006; Teerlink et al., 2007; Albright et al., 2008; Weires et al., 2005; Tashjian et al., 2009), among others. Dr. Albright continues to explore many different phenotypes using the UPDB. She is currently collaborating on the following phenotypes: head and neck cancers, lung cancer, ataxias, Alzheimers, spinal disorders, neurofibromatosis, celiac disease, influenza, asthma, thinness, tendonopathies, benign pituitary tumors, stroke, auto-immune disease, gallstone disease, sepsis, stroke, skeletal injury, and osteoarthritis.

Dr. Albright has recently built the genealogy of Utah and Massachusetts and record linked this genealogy to VA patients served in these states. This is part of a long-term plan to build the US genealogy and link to all 24 million VA patients nationwide.

Dr. Albright is interested in exploring new approaches and has directed a collaboration to develop analyses using high density SNP data to identify regions identical by descent within and between individuals in search of predisposition genes (Thomas et al., 2008). She has developed an innovative approach of mining existing tissue resources to obtain germline DNA for affected members of high-risk pedigrees to enable genetic studies for diseases that are quickly lethal.

Education History

Undergraduate Brigham Young University
 BS
Graduate Training University of Utah
 MStat
Doctoral Training University of Utah
 PhD

Selected Publications

Journal Article

  1. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2006). Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J, 152(2), 305-11.
  2. Anderson JL, Horne BD, Camp NJ, Muhlestein JB, Hopkins PN, Cannon-Albright LA, Mower CP, Park JJ, Clarke JL, Nicholas ZP, McKinney JT, Carlquist JF (2010). Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease. Am Heart J, 160(2), 250-256.e3.
  3. Marshall CJ, Schumann GB, Ward JH, Riding JM, Cannon-Albright LA, Skolnick MH. (1991). Cytologic identification of clinically occult proliferative breast disease in women with a family history of breast cancer. Am J Clin Pathol, 95:2, 157-165.
  4. Cannon-Albright LA, Bishop DT, Samowitz W, DiSario JA, Lee R, Burt RW (1994). Colonic polyps in an unselected population: prevalence, characteristics, and associations. Am J Gastroenterol, 89(6), 827-31.
  5. Maul JS, Warner NR, Kuwada SK, Burt RW, Cannon-Albright LA (2006). Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database. Am J Gastroenterol, 101(7), 1591-6.
  6. Cannon-Albright LA, Goldgar DE, Wright EC, Turco A, Jost M, Meyer LJ, Piepkorn M, Zone JJ, Skolnick MH (1990). Evidence against the reported linkage of the cutaneous melanoma-dysplastic nevus syndrome locus to chromosome Ip36. Am J Hum Genet, 46(5), 912-8.
  7. Goldgar DE, Cannon-Albright LA, Oliphant A, Ward JH, Linker G, Swensen J, Tran TD, Fields P, Uharriet P, Skolnick MH (1993). Chromosome 17q linkage studies of 18 Utah breast cancer kindreds. Am J Hum Genet, 52(4), 743-8.
  8. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Struewing J, Tonin P, Durocher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lyonnet D, Easton D, King MC, Goldgar DE (1996). Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet, 58(2), 271-80.
  9. Easton DF, Steele L, Fields P, Ormiston W, Averill D, Daly PA, McManus R, Neuhausen SL, Ford D, Wooster R, Cannon-Albright LA, Stratton MR, Goldgar DE (1997). Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet, 61(1), 120-8.
  10. Neuhausen SL, Godwin AK, Gershoni-Baruch R, Schubert E, Garber J, Stoppa-Lyonnet D, Olah E, Csokay B, Serova O, Lalloo F, Osorio A, Stratton M, Offit K, Boyd J, Caligo MA, Scott RJ, Schofield A, Teugels E, Schwab M, Cannon-Albright L, Bishop T, Easton D, Benitez J, King MC, Ponder BA, Weber B, Devilee P, Borg A, Narod SA, Goldgar D (1998). Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet, 62(6), 1381-8.
  11. Abkevich V, Camp NJ, Hensel CH, Neff CD, Russell DL, Hughes DC, Plenk AM, Lowry MR, Richards RL, Carter C, Frech GC, Stone S, Rowe K, Chau CA, Cortado K, Hunt A, Luce K, O'Neil G, Poarch J, Potter J, Poulsen GH, Saxton H, Bernat-Sestak M, Thompson V, Gutin A, Skolnick MH, Shattuck D, Cannon-Albright L (2003). Predisposition locus for major depression at chromosome 12q22-12q23.2. Am J Hum Genet, 73(6), 1271-81.
  12. Allen-Brady K, Norton PA, Farnham JM, Teerlink C, Cannon-Albright LA (2009). Significant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21. Am J Hum Genet, 84(5), 678-82.
  13. Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, Musolf A, Li Q, Holzinger E, Karyadi D, Cannon-Albright LA, Teerlink CC, Stanford JL, Isaacs WB, Xu J, Cooney KA, Lange EM, Schleutker J, Carpten JD, Powell IJ, Cussenot O, Cancel-Tassin G, Giles GG, MacInnis RJ, Maier C, Hsieh CL, Wiklund F, Catalona WJ, Foulkes WD, Mandal D, Eeles RA, Kote-Jarai Z, Bustamante CD, Schaid DJ, Hastie T, Ostrander EA, Bailey-Wilson JE, Radivojac P, Thibodeau SN, Whittemore AS, Sieh W (2016). REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet, 99(4), 877-885.
  14. Thompson D, Easton D, on behalf of the Breast Cancer Linkage Consortium, Cannon-Albright LA (2000). Variation in cancer risks by mutation position in BRCA2 mutation carriers. Am J Hum Genet, 68(2), 410-9.
  15. Xu J, and the International Consortium for Prostate Cancer Genetics (ICPCG) (2000). Combined analysis of hereditary prostate cancer linkage to 1q24-25: Results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics. Am J Hum Genet, 66(3), 945-57.
  16. Atkin CL, Hasstedt SJ, Menlove L, Cannon-Albright LA, Kirschner N, Schwartz C, Nguyen K, Kinkel L, Bruns G, Skolnick MH (1988). Mapping of alport syndrome to the long arm of the X Chromosome. Am J Hum Genet, 42, 249-255.
  17. Ford D, Easton DF, Stratton M, Narod S, Goldgar D, Devilee P, Bishop DT, Weber B, Lenoir G, Chang-Claude J, Sobol H, Teare MD, Struewing J, Arason A, Scherneck S, Peto J, Rebbeck TR, Tonin P, Neuhausen S, Barkardottir R, Eyfjord J, Lynch H, Ponder BAJ, Gayther SA, Birch JM, Lindblom A, Stoppa-Lyonnetd, Bigon Y, Borg A, Hamann U, Haites N, Scotdt RJ, Maugard CM, Vasen H, Seitz S, Cannon-Albright LA, Schofield A, Hedman MZ, Breast Cancer Linkage Consortium (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. Am J Hum Genet, 62(3), 676-89.
  18. Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Bishop T, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Hsieh CL, Halpern J, Balise RN, Oakley-Girvan I, Whittemore AS, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Thibodeau SN, McDonnell SK, Cunningham JM, Zarfas KE, Hebbring S, Schaid DJ, Friedrichsen DM, Deutsch K, Kolb S, Badzioch M, Jarvik GP, Janer M, Hood L, Ostrander EA, Stanford JL, Lange EM, Beebe-Dimmer JL, Mohai CE, Cooney KA, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TLj, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Seminara D, ACTANE Consortium (2005). A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet, 77(2), 219-29.
  19. Kivlin JD, Sanborn, GE, Wright E, Cannon L, Carey J (1987). Brief Clinical Report: Further linkage data on Norrie disease. Am J Med Genet, 26(3), 733-6.
  20. Goldfarb-Rumyantzev AS, Cheung AK, Habib AN, Wang BJ, Lin SJ, Baird BC, Naiman N, Cannon-Albright L (2006). A population-based assessment of the familial component of chronic kidney disease mortality. Am J Nephrol, 26(2), 142-8.
  21. Allen-Brady K, Cannon-Albright LA, Farnham JM, Norton PA (2015). Evidence for pelvic organ prolapse predisposition genes on chromosomes 10 and 17. Am J Obstet Gynecol, 212(6), 771.e1-7.
  22. Morgan TK, Allen-Brady KL, Monson MA, Leclair CM, Sharp HT, Cannon-Albright LA (2016). Familiality analysis of provoked vestibulodynia treated by vestibulectomy supports genetic predisposition. Am J Obstet Gynecol, 214(5), 609.e1-7.
  23. Horne BD, Carlquist JF, Cannon-Albright LA, Muhlestein JB, McKinney JT, Kolek MJ, Clarke JL, Anderson JL, Camp NJ (2006). High-resolution characterization of linkage disequilibrium structure and selection of tagging single nucleotide polymorphisms: application to the cholesteryl ester transfer protein gene. Ann Hum Genet, 70(Pt 4), 524-34.
  24. Thomas A, Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA (2008). Shared genomic segment analysis. Mapping disease predisposition genes in extended pedigrees using SNP genotype assays. Ann Hum Genet, 72(Pt 2), 279-87.
  25. Burt RW, DiSario JA, Cannon-Albright LA: (1995). Genetics of colon cancer: Impact of inheritance on colon cancer risk. Annu Rev Med, 46, 371-79.
  26. Eliason MJ, Hansen CB, Hart M, Porter-Gill P, Chen W, Sturm RA, Bowen G, Florell SR, Harris RM, Cannon-Albright LA, Swinyer L, Leachman SA (2007). Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation. Arch Dermatol, 143(11), 1409-12.
  27. Kareus SA, Figueroa KP, Cannon-Albright LA, Pulst SM (2012). Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study. Arch Neurol, 69(12), 1572-7.
  28. Davies NM, Gaunt TR, Lewis SJ, Holly J, Donovan JL, Hamdy FC, Kemp JP, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Smith GD, Martin RM (2015). The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium. Cancer Causes Control, 26(11), 1603-16.
  29. Skolnick MH, Cannon-Albright LA, Kamb A (1994). Genetic predisposition to melanoma. Eur J Cancer, 30A(13), 1991-5.
  30. Saunders EJ, Dadaev T, Leongamornlert DA, Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K, Easton DF, Eeles RA, Kote-Jarai Z (2016). Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array.LID - 10.1038/bjc.2016.50 [doi].(Epub ahead of print). Br J Cancer.
  31. Khankari NK, Murff HJ, Zeng C, Wen W, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Donovan JL, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Zheng W (2016). Polyunsaturated fatty acids and prostate cancer risk: a Mendelian randomisation analysis from the PRACTICAL consortium. Br J Cancer, 115(5), 624-31.
  32. Del Risco Kollerud R, Blaasaas KG, Claussen B, Nafstad P, Cannon-Albright LA, Ruud E, Wesenberg F, Næss Ø (2018). Family history of cancer and the risk of childhood solid tumours: a Norwegian nationwide register-based cohort study. Br J Cancer, 118(6), 905-912.
  33. Hawkes JE, Cassidy PB, Manga P, Boissy RE, Goldgar D, Cannon-Albright L, Florell SR, Leachman SA (2013). Report of a novel OCA2 gene mutation and an investigation of OCA2 variants on melanoma risk in a familial melanoma pedigree. J Dermatol Sci, 69(1), 30-7.
  34. Neuhausen SL, Skolnick MH, Cannon-Albright L (1997). Familial prostate cancer studies in Utah. Br J Urol, 79 Suppl 1, 15-20.
  35. Seibert TM, Fan CC, Wang Y, Zuber V, Karunamuni R, Parsons JK, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Garcia SB, Muir K, Gronberg H, Wiklund F, Aly M, Schleutker J, Sipeky C, Tammela TL, Nordestgaard BG, Nielsen SF, Weischer M, Bisbjerg R, Roder MA, Iversen P, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Cuk K, Saum KU, Park JY, Sellers TA, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Karow DS, Mills IG, Andreassen OA, Dale AM (2018). Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts. BMJ, 360, j5757.
  36. Allen-Brady K, Cannon-Albright LA, Neuhausen SL, Camp NJ (2006). A role for XRCC4 in age at diagnosis and breast cancer risk. Cancer Epidemiol Biomarkers Prev, 15(7), 1306-10.
  37. Camp NJ, Farnham JM, Wong J, Christensen GB, Thomas A, Cannon-Albright LA (2009). Replication of the 10q11 and Xp11 prostate cancer risk variants: results from a Utah pedigree-based study. Cancer Epidemiol Biomarkers Prev, 18(4), 1290-4.
  38. Gaudet MM, Milne RL, Cox A, Camp NJ, Goode EL, Humphreys MK, Dunning AM, Morrison J, Giles GG, Severi G, Baglietto L, English DR, Couch FJ, Olson JE, Wang X, Chang-Claude J, Flesch-Janys D, Abbas S, Salazar R, Mannermaa A, Kataja V, Kosma VM, Lindblom A, Margolin S, Heikkinen T, Kampjarvi K, Aaltonen K, Nevanlinna H, Bogdanova N, Coinac I, Schurmann P, Dork T, Bartram CR, Schmutzler RK, Tchatchou S, Burwinkel B, Brauch H, Torres D, Hamann U, Justenhoven C, Ribas G, Arias JI, Benitez J, Bojesen SE, Nordestgaard BG, Flyger HL, Peto J, Fletcher O, Johnson N, Dos Santos Silva I, Fasching PA, Beckmann MW, Strick R, Ekici AB, Broeks A, Schmidt MK, van Leeuwen FE, Van't Veer LJ, Southey MC, Hopper JL, Apicella C, Haiman CA, Henderson BE, Le Marchand L, Kolonel LN, Kristensen V, Grenaker Alnaes G, Hunter DJ, Kraft P, Cox DG, Hankinson SE, Seynaeve C, Vreeswijk MP, Tollenaar RA, Devilee P, Chanock S, Lissowska J, Brinton L, Peplonska B, Czene K, Hall P, Li Y, Liu J, Balasubramanian S, Rafii S, Reed MW, Pooley KA, Conroy D, Baynes C, Kang D, Yoo KY, Noh DY, Ahn SH, Shen CY, Wang HC, Yu JC, Wu PE, Anton-Culver H, Ziogoas A, Egan K, Newcomb P, Titus-Ernstoff L, Trentham Dietz A, Sigurdson AJ, Alexander BH, Bhatti P, Allen-Brady K, Cannon-Albright LA, Wong J, Chenevix-Trench G, Spurdle AB, Beesley J, Pharoah PD, Easton DF, Garcia-Closas M (2009). Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev, 18(5), 1610-6.
  39. Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Smith G, Bishop DT, Cox A, Camp NJ, Colorectal Cancer Study Group. (2009). Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev, 18(9), 2476-84.
  40. Jones KB, Schiffman JD, Kohlmann W, Randall RL, Lessnick SL, Cannon-Albright LA (2011). Complex genotype sarcomas display familial inheritance independent of known cancer predisposition syndromes. Cancer Epidemiol Biomarkers Prev, 20(5), 751-7.
  41. Camp NJ, Parry M, Knight S, Abo R, Elliott G, Rigas SH, Balasubramanian SP, Reed MW, McBurney H, Latif A, Newman WG, Cannon-Albright LA, Evans DG, Cox A (2012). Fine-mapping CASP8 risk variants in breast cancer. Cancer Epidemiol Biomarkers Prev, 21(1), 176-81.
  42. Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, Ostrander EA, Stanford JL, Batra J, Clements JA, Chambers SK, Weischer M, Nordestgaard BG, Ingles SA, Sorensen KD, Orntoft TF, Park JY, Cybulski C, Maier C, Doerk T, Dickinson JL, Cannon-Albright L, Brenner H, Rebbeck TR, Zeigler-Johnson C, Habuchi T, Thibodeau SN, Cooney KA, Chappuis PO, Hutter P, Kaneva RP, Foulkes WD, Zeegers MP, Lu YJ, Zhang HW, Stephenson R, Cox A, Southey MC, Spurdle AB, FitzGerald L, Leongamornlert D, Saunders E, Tymrakiewicz M, Guy M, Dadaev T, Little SJ, Govindasami K, Sawyer E, Wilkinson R, Herkommer K, Hopper JL, Lophatonanon A, Rinckleb AE, Kote-Jarai Z, Eeles RA, Easton DF (2015). Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev, 24(7), 1121-9.
  43. Szulkin R, Karlsson R, Whitington T, Aly M, Gronberg H, Eeles RA, Easton DF, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Southey MC, FitzGerald LM, Henderson BE, Schumacher FR, Haiman CA, Sipeky C, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Lubinski J, Kluzniak W, Cannon-Albright L, Brenner H, Herrmann V, Holleczek B, Park JY, Sellers TA, Lim HY, Slavov C, Kaneva RP, Mitev VI, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Batra J, Clements JA, Albanes D, Andriole GL, Berndt SI, Chanock S, Gapstur SM, Giovannucci EL, Hunter DJ, Kraft P, Le Marchand L, Ma J, Mondul AM, Penney KL, Stampfer MJ, Stevens VL, Weinstein SJ, Trichopoulou A, Bueno-de-Mesquita BH, Tjonneland A, Cox DG, Maehle L, Schleutker J, Lindstrom S, Wiklund F (2015). Genome-wide association study of prostate cancer-specific survival. Cancer Epidemiol Biomarkers Prev, 24(11), 1796-800.
  44. Rand KA, Song C, Dean E, Serie DJ, Curtin K, Sheng X, Hu D, Huff CA, Bernal-Mizrachi L, Tomasson MH, Ailawadhi S, Singhal S, Pawlish K, Peters ES, Bock CH, Stram A, Van Den Berg DJ, Edlund CK, Conti DV, Zimmerman T, Hwang AE, Huntsman S, Graff J, Nooka A, Kong Y, Pregja SL, Berndt SI, Blot WJ, Carpten J, Casey G, Chu L, Diver WR, Stevens VL, Lieber MR, Goodman PJ, Hennis AJ, Hsing AW, Mehta J, Kittles RA, Kolb S, Klein EA, Leske C, Murphy AB, Nemesure B, Neslund-Dudas C, Strom SS, Vij R, Rybicki BA, Stanford JL, Signorello LB, Witte JS, Ambrosone CB, Bhatti P, John EM, Bernstein L, Zheng W, Olshan AF, Hu JJ, Ziegler RG, Nyante SJ, Bandera EV, Birmann BM, Ingles SA, Press MF, Atanackovic D, Glenn MJ, Cannon-Albright LA, Jones B, Tricot G, Martin TG, Kumar SK, Wolf JL, Deming Halverson SL, Rothman N, Brooks-Wilson AR, Rajkumar SV, Kolonel LN, Chanock SJ, Slager SL, Severson RK, Janakiraman N, Terebelo HR, Brown EE, De Roos AJ, Mohrbacher AF, Colditz GA, Giles GG, Spinelli JJ, Chiu BC, Munshi NC, Anderson KC, Levy J, Zonder JA, Orlowski RZ, Lonial S, Camp NJ, Vachon CM, Ziv E, Stram DO, Hazelett DJ, Haiman CA, Cozen W (2016). A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci. Cancer Epidemiol Biomarkers Prev, 25(12), 1609-1618.
  45. Curtin K, Lin WY, George R, Katory M, Shorto J, Cannon-Albright LA, Bishop DT, Cox A, Camp NJ, Colorectal Cancer Study Group (2009). Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev, 18(2), 616-21.
  46. Thompson D, Easton D, on behalf of the Breast Cancer Linkage Consortium (2002). Variation in BRCA1 cancer risks by mutation position. Cancer Epidemiol Biomarkers Prev, 11, 329-336.
  47. Yu OH, Foulkes WD, Dastani Z, Martin RM, Eeles R, PRACTICAL Consortium, CRUK GWAS Investigators, Richards JB. (2013). An assessment of the shared allelic architecture between type II diabetes and prostate cancer. Cancer Epidemiol Biomarkers Prev, 22(8), 1473-5.
  48. Neuhausen SL, Farnham JM, Kort E, Tavtigian SV, Skolnick MH, Cannon-Albright LA (1999). Prostate cancer susceptibility locus HPC1 in Utah high-risk pedigrees. Hum Mol Genet, 8(13), 2437-42.
  49. Camp NJ, Cannon-Albright LA, Farnham JM, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Grönberg H, Wiklund F, Emanuelsson M, Isaacs WB, International Consortium for Prostate Cancer Genetics. (2007). Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet, 16(11), 1271-8.
  50. Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, Giovannucci EL, Siddiq A, Travis RC, Cox DG, Canzian F, Riboli E, Key TJ, Andriole G, Albanes D, Hayes RB, Schleutker J, Auvinen A, Tammela TL, Weischer M, Stanford JL, Ostrander EA, Cybulski C, Lubinski J, Thibodeau SN, Schaid DJ, Sorensen KD, Batra J, Clements JA, Chambers S, Aitken J, Gardiner RA, Maier C, Vogel W, Dork T, Brenner H, Habuchi T, Ingles S, John EM, Dickinson JL, Cannon-Albright L, Teixeira MR, Kaneva R, Zhang HW, Lu YJ, Park JY, Cooney KA, Muir KR, Leongamornlert DA, Saunders E, Tymrakiewicz M, Mahmud N, Guy M, Govindasami K, O'Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Virtamo J, Le Marchand L, Campa D, Kaaks R, Lindstrom S, Diver WR, Gapstur S, Yeager M, Cox A, Stern MC, Corral R, Aly M, Isaacs W, Adolfsson J, Xu J, Zheng SL, Wahlfors T, Taari K, Kujala P, Klarskov P, Nordestgaard BG, Roder MA, Frikke-Schmidt R, Bojesen SE, FitzGerald LM, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Rinckleb A, Luedeke M, Herkommer K, Meyer A, Serth J, Marthick JR, Patterson B, Wokolorczyk D, Spurdle A, Lose F, McDonnell SK, Joshi AD, Shahabi A, Pinto P, Santos J, Ray A, Sellers TA, Lin HY, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA (2013). A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet, 22(2), 408-15.
  51. Kote-Jarai Z, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Dadaev T, Jugurnauth-Little S, Ross-Adams H, Al Olama AA, Benlloch S, Halim S, Russell R, Dunning AM, Luccarini C, Dennis J, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle A, Clements JA, Teixeira MR, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dicks E, Baynes C, Conroy D, Bojesen SE, Kaaks R, Vincent D, Bacot F, Tessier DC, Easton DF, Eeles RA (2013). Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet, 22(12), 2520-8.
  52. Amin Al Olama A, Dadaev T, Hazelett DJ, Li Q, Leongamornlert D, Saunders EJ, Stephens S, Cieza-Borrella C, Whitmore I, Benlloch Garcia S, Giles GG, Southey MC, Fitzgerald L, Gronberg H, Wiklund F, Aly M, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, Mcdonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Arndt V, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Govindasami K, Guy M, Lophatonanon A, Muir K, Vinuela A, Brown AA, Freedman M, Conti DV, Easton D, Coetzee GA, Eeles RA, Kote-Jarai Z (2015). Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans. Hum Mol Genet, 24(19), 5589-602.
  53. Luedeke M, Rinckleb AE, FitzGerald LM, Geybels MS, Schleutker J, Eeles RA, Teixeira MR, Cannon-Albright L, Ostrander EA, Weikert S, Herkommer K, Wahlfors T, Visakorpi T, Leinonen KA, Tammela TL, Cooper CS, Kote-Jarai Z, Edwards S, Goh CL, McCarthy F, Parker C, Flohr P, Paulo P, Jeronimo C, Henrique R, Krause H, Wach S, Lieb V, Rau TT, Vogel W, Kuefer R, Hofer MD, Perner S, Rubin MA, Agarwal AM, Easton DF, Amin Al Olama A, Benlloch S, Hoegel J, Stanford JL, Maier C (2016). Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status.LID - ddw349 [pii]. Hum Mol Genet, 25(24), 5490-5499.
  54. Neuhausen SL, Swensen JJ, Miki Y, Liu Q, Tavtigian S, Shattuck-Eidens D, Kamb A, Hobbs MR, Gingrich J, Shizuya H, Him U-J, Cochran C, Futreal PA, Wiseman RW, Lynch HT, Tonin P, Narod S, Cannon-Albright L, Skolnick MH, Goldgar D (1994). A P1-based physical map of the BRCA1 region from D17S776 to D17S78. Hum Mol Genet, 3(11), 1919-1926.
  55. Machiela MJ, Lan Q, Slager SL, Vermeulen RC, Teras LR, Camp NJ, Cerhan JR, Spinelli JJ, Wang SS, Nieters A, Vijai J, Yeager M, Wang Z, Ghesquières H, McKay J, Conde L, de Bakker PI, Cox DG, Burdett L, Monnereau A, Flowers CR, De Roos AJ, Brooks-Wilson AR, Giles GG, Melbye M, Gu J, Jackson RD, Kane E, Purdue MP, Vajdic CM, Albanes D, Kelly RS, Zucca M, Bertrand KA, Zeleniuch-Jacquotte A, Lawrence C, Hutchinson A, Zhi D, Habermann TM, Link BK, Novak AJ, Dogan A, Asmann YW, Liebow M, Thompson CA, Ansell SM, Witzig TE, Tilly H, Haioun C, Molina TJ, Hjalgrim H, Glimelius B, Adami HO, Roos G, Bracci PM, Riby J, Smith MT, Holly EA, Cozen W, Hartge P, Morton LM, Severson RK, Tinker LF, North KE, Becker N, Benavente Y, Boffetta P, Brennan P, Foretova L, Maynadie M, Staines A, Lightfoot T, Crouch S, Smith A, Roman E, Diver WR, Offit K, Zelenetz A, Klein RJ, Villano DJ, Zheng T, Zhang Y, Holford TR, Turner J, Southey MC, Clavel J, Virtamo J, Weinstein S, Riboli E, Vineis P, Kaaks R, Boeing H, Tjønneland A, Angelucci E, Di Lollo S, Rais M, De Vivo I, Giovannucci E, Kraft P, Huang J, Ma B, Ye Y, Chiu BC, Liang L, Park JH, Chung CC, Weisenburger DD, Fraumeni JF Jr, Salles G, Glenn M, Cannon-Albright L, Curtin K, Wu X, Smedby KE, de Sanjose S, Skibola CF, Berndt SI, Birmann BM, Chanock SJ, Rothman N (2016). Genetically predicted longer telomere length is associated with increased risk of B-cell lymphoma subtypes. Hum Mol Genet, 25(8), 1663-76.
  56. Swensen J, Lewis CM, Cannon-Albright LA (1997). Identification of a one-base germline deletion (codon 888 del C) and an intron splice acceptor site polymorphism in hMSH2. Hum Mutat, 10(1), 80-1.
  57. Phelan CM, Rebbeck TR, Weber BL, Devilee P, Ruttledge MH, Lynch HT, Lenoir GM, Stratton MR, Easton DF, Ponder BA, Cannon-Albright L, Larsson C, Goldgar DE, Narod SA (1996). Ovarian cancer risk in BRCA1 carriers is modified by the HRAS1 variable number of tandem repeat (VNTR) locus. Nat Genet, 12(3), 309-11.
  58. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Merajver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc JF, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swense J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AK, Shizuya H, Eyfjord JE, Cannon-Albright L, Tranchant M, Labrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE (1996). The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet, 12(3), 333-7.
  59. Tavtigian SV, Simard J, Teng DH, Abtin V, Baumgard M, Beck A, Camp NJ, Carillo AR, Chen Y, Dayananth P, Desrochers M, Dumont M, Farnham JM, Frank D, Frye C, Ghaffari S, Gupte JS, Hu R, Iliev D, Janecki T, Kort EN, Laity KE, Leavitt A, Leblanc G, McArthur-Morrison J, Pederson A, Penn B, Peterson KT, Reid JE, Richards S, Schroeder M, Smith R, Snyder SC, Swedlund B, Swensen J, Thomas A, Tranchant M, Woodland AM, Labrie F, Skolnick MH, Neuhausen S, Rommens J, Cannon-Albright LA (2001). A candidate prostate cancer susceptibility gene at chromosome 17p. Nat Genet, 27(2), 172-80.
  60. Eeles RA, Kote-Jarai Z, Al Olama AA, Giles GG, Guy M, Severi G, Muir K, Hopper JL, Henderson BE, Haiman CA, Schleutker J, Hamdy FC, Neal DE, Donovan JL, Stanford JL, Ostrander EA, Ingles SA, John EM, Thibodeau SN, Schaid D, Park JY, Spurdle A, Clements J, Dickinson JL, Maier C, Vogel W, Dork T, Rebbeck TR, Cooney KA, Cannon-Albright L, Chappuis PO, Hutter P, Zeegers M, Kaneva R, Zhang HW, Lu YJ, Foulkes WD, English DR, Leongamornlert DA, Tymrakiewicz M, Morrison J, Ardern-Jones AT, Hall AL, O'Brien LT, Wilkinson RA, Saunders EJ, Page EC, Sawyer EJ, Edwards SM, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Southey MC, Lophatananon A, Liu JF, Kolonel LN, Le Marchand L, Wahlfors T, Tammela TL, Auvinen A, Lewis SJ, Cox A, FitzGerald LM, Koopmeiners JS, Karyadi DM, Kwon EM, Stern MC, Corral R, Joshi AD, Shahabi A, McDonnell SK, Sellers TA, Pow-Sang J, Chambers S, Aitken J, Gardiner RA, Batra J, Kedda MA, Lose F, Polanowski A, Patterson B, Serth J, Meyer A, Luedeke M, Stefflova K, Ray AM, Lange EM, Farnham J, Khan H, Slavov C, Mitkova A, Cao G, Easton DF (2009). Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet, 41(10), 1116-21.
  61. Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H, Hunter DJ, Kraft P, Thun MJ, Ingles S, Chanock S, Albanes D, Hayes RB, Neal DE, Hamdy FC, Donovan JL, Pharoah P, Schumacher F, Henderson BE, Stanford JL, Ostrander EA, Sorensen KD, Dork T, Andriole G, Dickinson JL, Cybulski C, Lubinski J, Spurdle A, Clements JA, Chambers S, Aitken J, Gardiner RA, Thibodeau SN, Schaid D, John EM, Maier C, Vogel W, Cooney KA, Park JY, Cannon-Albright L, Brenner H, Habuchi T, Zhang HW, Lu YJ, Kaneva R, Muir K, Benlloch S, Leongamornlert DA, Saunders EJ, Tymrakiewicz M, Mahmud N, Guy M, O'Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English DR, Wahlfors T, Tammela TL, Klarskov P, Nordestgaard BG, Roder MA, Tybjaerg-Hansen A, Bojesen SE, Travis R, Canzian F, Kaaks R, Wiklund F, Aly M, Lindstrom S, Diver WR, Gapstur S, Stern MC, Corral R, Virtamo J, Cox A, Haiman CA, Le Marchand L, Fitzgerald L, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Meyer A, Serth J, Yeager M, Berndt SI, Marthick JR, Patterson B, Wokolorczyk D, Batra J, Lose F, McDonnell SK, Joshi AD, Shahabi A, Rinckleb AE, Ray A, Sellers TA, Lin HY, Stephenson RA, Farnham J, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V, Easton DF, Eeles RA (2011). Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet, 43(8), 785-91.
  62. Barrett JH, Iles MM, Harland M, Taylor JC, Aitken JF, Andresen PA, Akslen LA, Armstrong BK, Avril MF, Azizi E, Bakker B, Bergman W, Bianchi-Scarra G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Corda E, Cust AE, Debniak T, Duffy D, Dunning AM, Easton DF, Friedman E, Galan P, Ghiorzo P, Giles GG, Hansson J, Hocevar M, Hoiom V, Hopper JL, Ingvar C, Janssen B, Jenkins MA, Jonsson G, Kefford RF, Landi G, Landi MT, Lang J, Lubinski J, Mackie R, Malvehy J, Martin NG, Molven A, Montgomery GW, van Nieuwpoort FA, Novakovic S, Olsson H, Pastorino L, Puig S, Puig-Butille JA, Randerson-Moor J, Snowden H, Tuominen R, Van Belle P, van der Stoep N, Whiteman DC, Zelenika D, Han J, Fang S, Lee JE, Wei Q, Lathrop GM, Gillanders EM, Brown KM, Goldstein AM, Kanetsky PA, Mann GJ, Macgregor S, Elder DE, Amos CI, Hayward NK, Gruis NA, Demenais F, Bishop JA, Bishop DT (2011). Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet, 43(11), 1108-13.
  63. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Roder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC, Kote-Jarai Z, Easton DF (2013). Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet, 45(4), 385-91, 391e1-2.
  64. Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, Cozen W, Monnereau A, Wang SS, Kelly RS, Lan Q, Teras LR, Chatterjee N, Chung CC, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Armstrong BK, Cocco P, Zhang Y, Severi G, Zeleniuch-Jacquotte A, Lawrence C, Burdette L, Yuenger J, Hutchinson A, Jacobs KB, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Wang AH, Smedby KE, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Jones B, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Holly EA, Smith MT, Jackson RD, Tinker LF, Benavente Y, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Rabe KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Lanasa MC, Spector LG, Leis JF, Cunningham JM, Weinberg JB, Morrison VA, Caporaso NE, Norman AD, Linet MS, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Trichopoulos D, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RC, Travis RC, Giles GG, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Offit K, Zelenetz A, Klein RJ, Spinelli JJ, Bertrand KA, Laden F, Giovannucci E, Kraft P, Kricker A, Turner J, Vajdic CM, Ennas MG, Ferri GM, Miligi L, Liang L, Sampson J, Crouch S, Park JH, North KE, Cox A, Snowden JA, Wright J, Carracedo A, Lopez-Otin C, Bea S, Salaverria I, Martin-Garcia D, Campo E, Fraumeni JF Jr, de Sanjose S, Hjalgrim H, Cerhan JR, Chanock SJ, Rothman N, Slager SL (2013). Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet, 45(8), 868-76.
  65. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, Benlloch S, Hazelett DJ, Wang Z, Saunders E, Leongamornlert D, Lindstrom S, Jugurnauth-Little S, Dadaev T, Tymrakiewicz M, Stram DO, Rand K, Wan P, Stram A, Sheng X, Pooler LC, Park K, Xia L, Tyrer J, Kolonel LN, Le Marchand L, Hoover RN, Machiela MJ, Yeager M, Burdette L, Chung CC, Hutchinson A, Yu K, Goh C, Ahmed M, Govindasami K, Guy M, Tammela TL, Auvinen A, Wahlfors T, Schleutker J, Visakorpi T, Leinonen KA, Xu J, Aly M, Donovan J, Travis RC, Key TJ, Siddiq A, Canzian F, Khaw KT, Takahashi A, Kubo M, Pharoah P, Pashayan N, Weischer M, Nordestgaard BG, Nielsen SF, Klarskov P, Roder MA, Iversen P, Thibodeau SN, McDonnell SK, Schaid DJ, Stanford JL, Kolb S, Holt S, Knudsen B, Coll AH, Gapstur SM, Diver WR, Stevens VL, Maier C, Luedeke M, Herkommer K, Rinckleb AE, Strom SS, Pettaway C, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, Cannon-Albright L, Cybulski C, Wokolorczyk D, Kluzniak W, Park J, Sellers T, Lin HY, Isaacs WB, Partin AW, Brenner H, Dieffenbach AK, Stegmaier C, Chen C, Giovannucci EL, Ma J, Stampfer M, Penney KL, Mucci L, John EM, Ingles SA, Kittles RA, Murphy AB, Pandha H, Michael A, Kierzek AM, Blot W, Signorello LB, Zheng W, Albanes D, Virtamo J, Weinstein S, Nemesure B, Carpten J, Leske C, Wu SY, Hennis A, Kibel AS, Rybicki BA, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Zheng SL, Batra J, Clements J, Spurdle A, Teixeira MR, Paulo P, Maia S, Slavov C, Kaneva R, Mitev V, Witte JS, Casey G, Gillanders EM, Seminara D, Riboli E, Hamdy FC, Coetzee GA, Li Q, Freedman ML, Hunter DJ, Muir K, Gronberg H, Neal DE, Southey M, Giles GG, Severi G, Cook MB, Nakagawa H, Wiklund F, Kraft P, Chanock SJ, Henderson BE, Easton DF, Eeles RA, Haiman CA (2014). A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet, 46(10), 1103-9.
  66. Scott RH, Douglas J, Baskcomb L, Huxter N, Barker K, Hanks S, Craft A, Gerrard M, Kohler JA, Levitt GA, Picton S, Pizer B, Ronghe MD, Williams D, Factors Associated with Childhood Tumours (FACT) Collaboration, Cook JA, Pujol P, Maher ER, Birch JM, Stiller CA, Pritchard-Jones K, Rahman N. (2008). Constitutional 11p15 abnormalities, including heritable imprinting center mutations, cause nonsyndromic Wilms tumor. Nat Genet, 40(11), 1329-34.
  67. Bishop DT, Demenais F, Iles MM, Harland M, Taylor JC, Corda E, Randerson-Moor J, Aitken JF, Avril MF, Azizi E, Bakker B, Bianchi-Scarrà G, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Chin-A-Woeng T, Debniak T, Galore-Haskel G, Ghiorzo P, Gut I, Hansson J, Hocevar M, Höiom V, Hopper JL, Ingvar C, Kanetsky PA, Kefford RF, Landi MT, Lang J, Lubinski J, Mackie R, Malvehy J, Mann GJ, Martin NG, Montgomery GW, van Nieuwpoort FA, Novakovic S, Olsson H, Puig S, Weiss M, van Workum W, Zelenika D, Brown KM, Goldstein AM, Gillanders EM, Boland A, Galan P, Elder DE, Gruis NA, Hayward NK, Lathrop GM, Barrett JH, Bishop JA (2009). Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet, 41(8), 920-5.
  68. Stratton MR, Ford D, Neuhausen S, Seal S, Wooster R, Friedman LS, King M-C, Egilsson V, Devilee P, McMarus R, Daly PA, Smith E, Ponder BAJ, Pelo J, Cannon-Albright LA, Easton D, Goldgar D. (1994). Familial male breast cancer is not linked to BRCA1 locus on chromosome 17q. Nat Genet, 7(1), 103-7.
  69. Kamb A, Shattuck-Eidens D, Eeles R, Liu Q, Gris NA, Ding W, Hussey C, Tran T, Miki Y, Weaver-Feldhaus J, McClure M, Aitken JF, Anderson DE, Bergman W, Frants R, Goldgar DE, Green A. MacLennan R, Martin NG, Meyer LJ, Youl P, Zone JJ, Skolnick MH, Cannon-Albright LA (1994). Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet, 8(1), 23-6.
  70. Cannon-Albright LA, Eeles R (1995). Progress in Prostate Cancer. Nat Genet, 9(4), 336-338.
  71. Bansal A, Farnham JM, Crapo RO, Hughes DC, Jensen RL, Cannon-Albright LA (2001). A simple diagnostic index for asthma. Clin Exp Allergy, 31(5), 756-60.
  72. Skolnick MH, Cannon-Albright LA (1992). Genetic predisposition to breast cancer. Cancer, 70(6 Suppl), 1747-54.
  73. Cannon-Albright LA, Thomas TC, Bishop DT, Skolnick MH, Burt RW (1989). Characteristics of familial colon cancer in a large population data base. Cancer, 64(9), 1971-5.
  74. Burt RW, Bishop DT, Cannon-Albright LA, Samowitz WS, Lee RL, Disario JA, Skolnick MH. (1992). Hereditary aspects of colorectal adenomas. Cancer, 70, 1296-1299.
  75. Burt RW, Bishop DT, Cannon-Albright LA, Samowitz WS, Lee RL, Disario JA, Skolnick MH. (1992). Population-genetics of colonic cancer. Cancer, 70, 1719-1722.
  76. Verhagen PC, Zhu XL, Rohr LR, Cannon-Albright LA, Tavtigian SV, Skolnick MH, Brothman AR (2000). Microdissection, DOP-PCR, and comparative genomic hybridization of paraffin-embedded familial prostate cancers. Cancer Genet Cytogenet, 122(1), 43-8.
  77. Livingston G, Cannon L, Bishop DT, Johnson P, Fineman R (1983). Sisterchromatid exchange: variation by age, sex, smoking and breast cancer status. Cancer Genet Cytogenet, 9(3), 289-99.
  78. Cannon-Albright LA, Meyer LJ, Goldgar DE, Lewis CM, McWhorter WP, Jost M, Harrison D, Anderson DE, Zone JJ, Skolnick MH (1994). Penetrance and expressivity of the chromosome 9p melanoma susceptibility locus (MLM). Cancer Res, 54(23), 6041-4.
  79. Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, Jacobsen M, McWhorter WP, Skolnick MH (1994). Familiality of cancer in Utah. Cancer Res, 54(9), 2378-85.
  80. Lewis CM, Neuhausen SL, Daley D, Black FJ, Swensen J, Burt RW, Cannon-Albright LA, Skolnick MH (1996). Genetic heterogeneity and unmapped genes for colorectal cancer. Cancer Res, 56(6), 1382-8.
  81. Camp NJ, Farnham JM, Cannon-Albright LA (2006). Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees. Cancer Res, 66(20), 10205-12.
  82. Shephard ND, Abo R, Rigas SH, Frank B, Lin WY, Brock IW, Shippen A, Balasubramanian SP, Reed MW, Bartram CR, Meindl A, Schmutzler RK, Engel C, Burwinkel B, Cannon-Albright LA, Allen-Brady K, Camp NJ, Cox A (2009). A breast cancer risk haplotype in the caspase-8 gene. Cancer Res, 69(7), 2724-8.
  83. Camp NJ, Lin WY, Bigelow A, Burghel GJ, Mosbruger TL, Parry MA, Waller RG, Rigas SH, Tai PY, Berrett K, Rajamanickam V, Cosby R, Brock IW, Jones B, Connley D, Sargent R, Wang G, Factor RE, Bernard PS, Cannon-Albright L, Knight S, Abo R, Werner TL, Reed MW, Gertz J, Cox A (2016). Discordant Haplotype Sequencing Identifies Functional Variants at the 2q33 Breast Cancer Risk Locus. Cancer Res, 76(7), 1916-25.
  84. Goldstein AM, Chan M, Harland M, Gillanders EM, Hayward NK, Avril MF, Azizi E, Bianchi-Scarra G, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon Albright LA, Demenais F, Elder DE, Ghiorzo P, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, Mackie RM, Magnusson V, Mann GJ, Niendorf K, Newton Bishop J, Palmer JM, Puig S, Puig-Butille JA, de Snoo FA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E, Melanoma Genetics Consortium (GenoMEL) (2006). High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res, 66(20), 9818-28.
  85. Cannon L, Bishop DT, Skolnick MH, Hunt S, Lyon JL, Smart C. (1982). Genetic epidemiology of prostate cancer in the Utah Mormon genealogy. Cancer Surv, 1(1), 48-69.
  86. Horne BD, Camp NJ, Muhlestein JB, Cannon-Albright LA (2004). Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation, 110(19), 3143-8.
  87. Rausch T, Thomas A, Camp NJ, Cannon-Albright LA, Facelli JC (2008). A parallel genetic algorithm to discover patterns in genetic markers that indicate predisposition to multifactorial disease. Comput Biol Med, 38(7), 826-36.
  88. Thomas A, Cannon-Albright L, Bansal A, Skolnick MH (1999). Familial associations between cancer sites. Comput Biomed Res, 32(6), 517-29.
  89. Meyer LJ, Goldgar DE, Cannon-Albright LA, Piepkorn MW, Zone JJ, Risman MB, Skolnick MH (1992). Number, size, and histopathology of nevi in Utah kindreds. Cytogenet Cell Genet, 59(2-3), 167-9.
  90. Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH (1992). Inheritance of nevus number and size in melanoma/DNS kindreds. Cytogenet Cell Genet, 59(2-3), 200-2.
  91. Samadder NJ, Cannon-Albright LA, Burt RW (2012). The impact of family history on the risk of colorectal neoplasia: don't change the guidelines just yet! Dig Dis Sci, 57(12), 3047-9.
  92. Panagiotou OA, Travis RC, Campa D, Berndt SI, Lindstrom S, Kraft P, Schumacher FR, Siddiq A, Papatheodorou SI, Stanford JL, Albanes D, Virtamo J, Weinstein SJ, Diver WR, Gapstur SM, Stevens VL, Boeing H, Bueno-de-Mesquita HB, Barricarte Gurrea A, Kaaks R, Khaw KT, Krogh V, Overvad K, Riboli E, Trichopoulos D, Giovannucci E, Stampfer M, Haiman C, Henderson B, Le Marchand L, Gaziano JM, Hunter DJ, Koutros S, Yeager M, Hoover RN, PRACTICAL Consortium, Chanock SJ, Wacholder S, Key TJ, Tsilidis KK (2015). A genome-wide pleiotropy scan for prostate cancer risk. Eur Urol, 67(4), 649-57.
  93. Taylor DP, Burt RW, Williams MS, Haug PJ, Cannon-Albright LA (2010). Population-based family history-specific risks for colorectal cancer: a constellation approach. Gastroenterology, 138(3), 877-85.
  94. Bishop DT, Cannon-Albright L, McLellan T, Gardner EJ, Skolnick MH (1988). Segregation and linkage analysis of nine Utah breast cancer pedigrees. Genet Epidemiol, 5(3), 151-69.
  95. Camp NJ, Gutin A, Abkevich V, Farnham JM, Cannon-Albright L, Thomas A (2001). A new nonparametric linkage statistic for mapping both qualitative and quantitative trait loci. Genet Epidemiol, 21 Suppl 1, S461-6.
  96. Abkevich V, Camp NJ, Gutin A, Farnham JM, Cannon-Albright L, Thomas A (2001). A robust multipoint linkage statistic (tlod) for mapping complex trait loci. Genet Epidemiol, 21 Suppl 1, S492-7.
  97. Gutin A, Abkevich V, Camp NJ, Farnham JM, Cannon-Albright L, Thomas A (2001). Allelic association in large pedigrees. Genet Epidemiol, 21 Suppl 1, S571-5.
  98. Bishop DT, Cannon LA, Hasstedt SH, Skolnick MH (1984). Genetic Analysis Workshop II: segregation and three-locus linkage analysis. Genet Epidemiol, 1(2), 161-5.
  99. Camp NJ, Swensen J, Horne BD, Farnham JM, Thomas A, Cannon-Albright LA, Tavtigian SV (2005). Characterization of linkage disequilibrium structure, mutation history, and tagging SNPs, and their use in association analyses: ELAC2 and familial early-onset prostate cancer. Genet Epidemiol, 28(3), 232-43.
  100. Larson NB, McDonnell S, Cannon Albright L, Teerlink C, Stanford J, Ostrander EA, Isaacs WB, Xu J, Cooney KA, Lange E, Schleutker J, Carpten JD, Powell I, Bailey-Wilson JE, Cussenot O, Cancel-Tassin G, Giles GG, MacInnis RJ, Maier C, Whittemore AS, Hsieh CL, Wiklund F, Catolona WJ, Foulkes W, Mandal D, Eeles R, Kote-Jarai Z, Ackerman MJ, Olson TM, Klein CJ, Thibodeau SN, Schaid DJ (2017). gsSKAT: Rapid gene set analysis and multiple testing correction for rare-variant association studies using weighted linear kernels. Genet Epidemiol, 41(4), 297-308.
  101. Skolnick MH, Thompson EA, Bishop DT, Cannon LA (1984). Possible linkage of a breast cancer susceptibility locus to the ABO locus: sensitivity of LOD scores to a single new recombinant observation. Genet Epidemiol, 1(4), 363-73.
  102. Bishop DT, Cannon LA, Hasstedt SJ, Skolnick MH. (1985). Genetic analysis workshop III: Multilocus linkage analysis using PAP. Genet Epidemiol, 2(2), 203-204.
  103. Dietz JN, Robbins T, Cannon LA, Schwartz CE, Carey JC, Johnson JP, Kivlin J, Skolnick MH. (1986). Linkage Analysis of Von Recklinghausen Neurofibromatosis: Chromosomes 4 and 19. Genet Epidemiol, 3(5), 313-21.
  104. Seger HM, Soisson AP, Dodson MK, Rowe KG, Cannon-Albright LA (2011). Familial clustering of endometrial cancer in a well-defined population. Gynecol Oncol, 122(1), 75-8.
  105. Monroe MM, Hashibe M, Orb Q, Alt J, Buchmann L, Hunt J, Cannon-Albright LA (2018). Familial clustering of oropharyngeal squamous cell carcinoma in the Utah population. Head Neck, 40(2), 384-393.
  106. Cannon Albright LA (2008). Utah family-based analysis: past, present and future. Hum Hered, 65(4), 209-20.
  107. Farnham JM, Camp NJ, Neuhausen SL, Tsuruda J, Parker D, MacDonald J, Cannon-Albright LA (2004). Confirmation of chromosome 7q11 locus for predisposition to intracranial aneurysm. Hum Genet, 114(3), 250-5.
  108. Schaid DJ, McDonnell SK, Zarfas KE, Cunningham JM, Hebbring S, Thibodeau SN, Eeles RA, Easton DF, Foulkes WD, Simard J, Giles GG, Hopper JL, Mahle L, Moller P, Badzioch M, Bishop DT, Evans C, Edwards S, Meitz J, Bullock S, Hope Q, Guy M, Hsieh CL, Halpern J, Balise RR, Oakley-Girvan I, Whittemore AS, Xu J, Dimitrov L, Chang BL, Adams TS, Turner AR, Meyers DA, Friedrichsen DM, Deutsch K, Kolb S, Janer M, Hood L, Ostrander EA, Stanford JL, Ewing CM, Gielzak M, Isaacs SD, Walsh PC, Wiley KE, Isaacs WB, Lange EM, Ho LA, Beebe-Dimmer JL, Wood DP, Cooney KA, Seminara D, Ikonen T, Baffoe-Bonnie A, Fredriksson H, Matikainen MP, Tammela TL, Bailey-Wilson J, Schleutker J, Maier C, Herkommer K, Hoegel JJ, Vogel W, Paiss T, Wiklund F, Emanuelsson M, Stenman E, Jonsson BA, Gronberg H, Camp NJ, Farnham J, Cannon-Albright LA, Catalona WJ, Suarez BK, Roehl KA (2006). Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet, 120(4), 471-85.
  109. Teerlink C, Farnham J, Allen-Brady K, Camp NJ, Thomas A, Leachman S, Cannon-Albright L (2012). A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q. Hum Genet, 131(1), 77-85.
  110. Jin G, Lu L, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Cannon-Albright LA, Camp NJ, Teerlink CC, Fitzgerald LM, Stanford JL, Wiley KE, Isaacs SD, Walsh PC, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Thibodeau SN, McDonnell SK, Schaid DJ, Wiklund F, Gronberg H, Emanuelsson M, Whittemore AS, Oakley-Girvan I, Hsieh CL, Wahlfors T, Tammela T, Schleutker J, Catalona WJ, Zheng SL, Ostrander EA, Isaacs WB, Xu J (2012). Validation of prostate cancer risk-related loci identified from genome-wide association studies using family-based association analysis: evidence from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet, 131(7), 1095-103.
  111. Xu J, Lange EM, Lu L, Zheng SL, Wang Z, Thibodeau SN, Cannon-Albright LA, Teerlink CC, Camp NJ, Johnson AM, Zuhlke KA, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Maier C, Luedeke M, Vogel W, Schleutker J, Wahlfors T, Tammela T, Schaid D, McDonnell SK, DeRycke MS, Cancel-Tassin G, Cussenot O, Wiklund F, Gronberg H, Eeles R, Easton D, Kote-Jarai Z, Whittemore AS, Hsieh CL, Giles GG, Hopper JL, Severi G, Catalona WJ, Mandal D, Ledet E, Foulkes WD, Hamel N, Mahle L, Moller P, Powell I, Bailey-Wilson JE, Carpten JD, Seminara D, Cooney KA, Isaacs WB (2013). HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet, 132(1), 5-14.
  112. Teerlink CC, Thibodeau SN, McDonnell SK, Schaid DJ, Rinckleb A, Maier C, Vogel W, Cancel-Tassin G, Egrot C, Cussenot O, Foulkes WD, Giles GG, Hopper JL, Severi G, Eeles R, Easton D, Kote-Jarai Z, Guy M, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Fitzgerald LM, Stanford JL, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Wahlfors T, Tammela T, Schleutker J, Wiklund F, Grönberg H, Emanuelsson M, Carpten J, Bailey-Wilson J, Whittemore AS, Oakley-Girvan I, Hsieh CL, Catalona WJ, Zheng SL, Jin G, Lu L, Xu J, International Consortium for Prostate Cancer Genetics., Camp NJ, Cannon-Albright LA (2014). Association analysis of 9,560 prostate cancer cases from the International Consortium of Prostate Cancer Genetics confirms the role of reported prostate cancer associated SNPs for familial disease. Hum Genet, 133(3), 347-56.
  113. Helfand BT, Roehl KA, Cooper PR, McGuire BB, Fitzgerald LM, Cancel-Tassin G, Cornu JN, Bauer S, Van Blarigan EL, Chen X, Duggan D, Ostrander EA, Gwo-Shu M, Zhang ZF, Chang SC, Jeong S, Fontham ET, Smith G, Mohler JL, Berndt SI, McDonnell SK, Kittles R, Rybicki BA, Freedman M, Kantoff PW, Pomerantz M, Breyer JP, Smith JR, Rebbeck TR, Mercola D, Isaacs WB, Wiklund F, Cussenot O, Thibodeau SN, Schaid DJ, Cannon-Albright L, Cooney KA, Chanock SJ, Stanford JL, Chan JM, Witte J, Xu J, Bensen JT, Taylor JA, Catalona WJ (2015). Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases. Hum Genet, 134(4), 439-50.
  114. Teerlink CC, Leongamornlert D, Dadaev T, Thomas A, Farnham J, Stephenson RA, Riska S, McDonnell SK, Schaid DJ, Catalona WJ, Zheng SL, Cooney KA, Ray AM, Zuhlke KA, Lange EM, Giles GG, Southey MC, Fitzgerald LM, Rinckleb A, Luedeke M, Maier C, Stanford JL, Ostrander EA, Kaikkonen EM, Sipeky C, Tammela T, Schleutker J, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Xu J, Cancel-Tassin G, Cussenot O, Mandal D, Laurie C, Laurie C, Thibodeau SN, Eeles RA, Kote-Jarai Z, Cannon-Albright L (2016). Genome-wide association of familial prostate cancer cases identifies evidence for a rare segregating haplotype at 8q24.21. Hum Genet, 135(8), 923-38.
  115. Farnham JM, Camp NJ, Swensen J, Tavtigian SV, Cannon-Albright LA (2004). Confirmation of the HPCX cancer predisposition locus in large Utah prostate cancer pedigrees. Hum Genet, 116(3), 179-85.
  116. Couch FJ, Rommens JM, Neuhausen SL, Belanger C, Dumont M, Abel K, Bell R, Berry S, Bogden R, Cannon-Albright L, Farid L, Frye C, Hattier T, Janecki T, Jiang P, Kehrer R, Leblanc JF, McArthur-Morrison J, Meney D, Miki Y, Peng Y, Samson C, Schroeder M, Snyder SC, Simard J, et al. (1996). Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics, 36(1), 86-99.
  117. Cannon-Albright LA, Goldgar DE, Neuhausen S, Gruis NA, Anderson DE, Lewis CM, Jost M, Tran TD, Nguyen K, Kamb A, Weaver-Feldhaus J, Meyer LJ, Zone JJ, Skolnick MH (1994). Localization of the 9p melanoma susceptibility locus (MLM) to a 2-cM region between D9S736 and D9S171. Genomics, 23(1), 265-8.
  118. Allen-Brady K, Camp NJ, Ward JH, Cannon-Albright LA (2005). Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer, 117(4), 655-61.
  119. Bonilla C, Lewis SJ, Rowlands MA, Gaunt TR, Smith GD, Gunnell D, Palmer T, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Martin RM, Holly JM (2016). Assessing the role of insulin-like growth factors and binding proteins in prostate cancer using Mendelian randomization: Genetic variants as instruments for circulating levels.LID - 10.1002/ijc.30206 [doi].(Epub ahead of print). Int J Cancer.
  120. Brunner C, Davies NM, Martin RM, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles G, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Donovan J, Hamdy FC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Zuccolo L (2017). Alcohol consumption and prostate cancer incidence and progression: A Mendelian randomisation study. Int J Cancer, 140(1), 75-85.
  121. Taylor AE, Martin RM, Geybels MS, Stanford JL, Shui I, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Blot W, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Donovan J, Munafo MR (2017). Investigating the possible causal role of coffee consumption with prostate cancer risk and progression using Mendelian randomization analysis. Int J Cancer, 140(2), 322-328.
  122. Narod SA, Goldgar D, Cannon-Albright LA, Weber B, Moslehi R, Ives E, Lenoir G, Lynch H (1995). Risk modifiers in carriers of BRCA1 mutations. Int J Cancer, 64 (6), 394-398.
  123. Tashjian RZ, Farnham JM, Albright FS, Teerlink CC, Cannon-Albright LA (2009). Evidence for an inherited predisposition contributing to the risk for rotator cuff disease. J Bone Joint Surg Am, 91(5), 1136-42.
  124. Patel AA, Spiker WR, Daubs M, Brodke D, Cannon-Albright LA (2011). Evidence for an inherited predisposition to lumbar disc disease. J Bone Joint Surg Am, 93(3), 225-9.
  125. Painter JN, Willemsen G, Nyholt D, Hoekstra C, Duffy DL, Henders AK, Wallace L, Healey S, Cannon-Albright LA, Skolnick M, Martin NG, Boomsma DI and Montgomery GW (2010). A genome wide linkage scan for dizygotic twinning in 525 families of mothers of dizygotic twins. Hum Reprod, 25(6), 1569-80.
  126. Piepkorn M, Meyer LJ, Goldgar D, Seuchter SA, Cannon-Albright LA, Skolnick MH, Zone JJ (1989). The dysplastic melanocytic nevus: a prevalent lesion that correlates poorly with clinical phenotype. J Am Acad Dermatol, 20(3), 407-15.
  127. Piepkorn MW, Barnhill RL, Cannon-Albright LA, Elder DE, Goldgar DE, Lewis CM, Maize JC, Meyer LJ, Rabkin MS, Sagebiel RW (1994). A multiobserver, population-based analysis of histologic dysplasia in melanocytic nevi. J Am Acad Dermatol, 30(5 Pt 1), 707-14.
  128. Meyer LJ, Piepkorn M, Goldgar DE, Lewis CM, Cannon-Albright LA, Zone JJ, Skolnick MH (1996). Interobserver concordance in discriminating clinical atypia of melanocytic nevi, and correlations with histologic atypia. J Am Acad Dermatol, 34(4), 618-25.
  129. Grossman D, Farnham JM, Hyngstrom J, Klapperich ME, Secrest AM, Empey S, Bowen GM, Wada D, Andtbacka RHI, Grossmann K, Bowles TL, Cannon-Albright LA (2018). Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011). J Am Acad Dermatol, 79(2), 238-244.
  130. Ahmed I, Piepkorn M, Goldgar DE, Cannon-Albright LA, Meyer LJ, Skolnick MH, Zone JJ (1991). HMB-45 staining of dysplastic melanocytic nevi in melanoma risk groups. J Cutan Pathol, 18(4), 257-60.
  131. Albright FS, Orlando P, Pavia AT, Jackson GG, Cannon Albright LA (2008). Evidence for a heritable predisposition to death due to influenza. J Infect Dis, 197(1), 18-24.
  132. Florell SR, Boucher KM, Holden JA, Meyer LJ, Samlowski WE, Cannon-Albright LA, Zone JJ, Leachman SA (2002). Failure to detect differences in proliferation status of nevi from CDKN2A mutation carriers and non-carriers. J Invest Dermatol, 118(2), 386-7.
  133. Florell SR, Meyer LJ, Boucher KM, Porter-Gill PA, Hart M, Erickson J, Cannon-Albright LA, Pershing LK, Harris RM, Samlowski WE, Zone JJ, Leachman SA (2004). Longitudinal assessment of the nevus phenotype in a melanoma kindred. J Invest Dermatol, 123(3), 576-82.
  134. Eliason MJ, Larson AA, Florell SR, Zone JJ, Cannon-Albright LA, Samlowski WE, Leachman SA (2006). Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol, 126(3), 660-6.
  135. Florell SR, Meyer LJ, Boucher KM, Grossman D, Cannon-Albright LA, Harris RM, Samlowski WE, Zone JJ, Leachman SA (2008). Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree. J Invest Dermatol, 128(8), 2122-5.
  136. Cannon-Albright LA, Teerlink CC, Farnham JM, Thomas AW, Zone JJ, Leachman SA (2013). Linkage analysis of extended high-risk pedigrees replicates a cutaneous malignant melanoma predisposition locus on chromosome 9q21. J Invest Dermatol, 133(1), 128-34.
  137. Taylor NJ, Handorf EA, Mitra N, Avril MF, Azizi E, Bergman W, Bianchi-Scarrà G, Bishop DT, Bressac-de Paillerets B, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Friedman E, Gerdes AM, Ghiorzo P, Goldstein AM, Grazziotin TC, Hansson J, Hayward NK, Hocevar M, Höiom V, Holland EA, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer J, Peri¿ B, Pjanova D, Puig S, Schmid H, van der Stoep N, Tucker MA, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA, GenoMEL Consortium. (2016). Phenotypic and Histopathological Tumor Characteristics According to CDKN2A Mutation Status among Affected Members of Melanoma Families. J Invest Dermatol, 136(5), 1066-1069.
  138. Taylor NJ, Mitra N, Goldstein AM, Tucker MA, Avril MF, Azizi E, Bergman W, Bishop DT, Bressac-de Paillerets B, Bruno W, Calista D, Cannon-Albright LA, Cuellar F, Cust AE, Demenais F, Elder DE, Gerdes AM, Ghiorzo P, Grazziotin TC, Hansson J, Harland M, Hayward NK, Hocevar M, Höiom V, Ingvar C, Landi MT, Landman G, Larre-Borges A, Leachman SA, Mann GJ, Nagore E, Olsson H, Palmer JM, Peri¿ B, Pjanova D, Pritchard A, Puig S, van der Stoep N, Wadt KAW, Whitaker L, Yang XR, Newton Bishop JA, Gruis NA, Kanetsky PA, GenoMEL Study Group. (2017). Germline Variation at CDKN2A and Associations with Nevus Phenotypes among Members of Melanoma Families. J Invest Dermatol, 137(12), 2606-2612.
  139. Larson AA, Leachman SA, Eliason MJ, Cannon-Albright LA (2007). Population-Based Assessment of Non-Melanoma Cancer Risk in Relatives of Cutaneous Melanoma Probands. J Invest Dermatol, 127(1), 183-8.
  140. Florell SR, Meyer LJ, Boucher KM, Hart M, Cannon-Albright LA, Harris RM, Grossman D, Samlowski WE, Zone JJ, Brinton JP, Leachman SA (2005). Nevus distribution in a Utah melanoma kindred with a temperature-sensitive CDKN2A mutation. J Invest Dermatol, 125(6), 1310-2.
  141. Lin WY, Camp NJ, Cannon-Albright LA, Allen-Brady K, Balasubramanian S, Reed MW, Hopper JL, Apicella C, Giles GG, Southey MC, Milne RL, Arias-Perez JI, Menendez-Rodriguez P, Benitez J, Grundmann M, Dubrowinskaja N, Park-Simon TW, Dork T, Garcia-Closas M, Figueroa J, Sherman M, Lissowska J, Easton DF, Dunning AM, Rajaraman P, Sigurdson AJ, Doody MM, Linet MS, Pharoah PD, Schmidt MK, Cox A (2011). A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet, 48(7), 477-84.
  142. Southey MC, Goldgar DE, Winqvist R, Pylkas K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dork T, Claes KB, Reis-Filho J, Teo ZL, Radice P, Catucci I, Peterlongo P, Tsimiklis H, Odefrey FA, Dowty JG, Schmidt MK, Broeks A, Hogervorst FB, Verhoef S, Carpenter J, Clarke C, Scott RJ, Fasching PA, Haeberle L, Ekici AB, Beckmann MW, Peto J, Dos-Santos-Silva I, Fletcher O, Johnson N, Bolla MK, Sawyer EJ, Tomlinson I, Kerin MJ, Miller N, Marme F, Burwinkel B, Yang R, Guenel P, Truong T, Menegaux F, Sanchez M, Bojesen S, Nielsen SF, Flyger H, Benitez J, Zamora MP, Perez JI, Menendez P, Anton-Culver H, Neuhausen S, Ziogas A, Clarke CA, Brenner H, Arndt V, Stegmaier C, Brauch H, Bruning T, Ko YD, Muranen TA, Aittomaki K, Blomqvist C, Bogdanova NV, Antonenkova NN, Lindblom A, Margolin S, Mannermaa A, Kataja V, Kosma VM, Hartikainen JM, Spurdle AB, Investigators K, Wauters E, Smeets D, Beuselinck B, Floris G, Chang-Claude J, Rudolph A, Seibold P, Flesch-Janys D, Olson JE, Vachon C, Pankratz VS, McLean C, Haiman CA, Henderson BE, Schumacher F, Le Marchand L, Kristensen V, Alnaes GG, Zheng W, Hunter DJ, Lindstrom S, Hankinson SE, Kraft P, Andrulis I, Knight JA, Glendon G, Mulligan AM, Jukkola-Vuorinen A, Grip M, Kauppila S, Devilee P, Tollenaar RA, Seynaeve C, Hollestelle A, Garcia-Closas M, Figueroa J, Chanock SJ, Lissowska J, Czene K, Darabi H, Eriksson M, Eccles DM, Rafiq S, Tapper WJ, Gerty SM, Hooning MJ, Martens JW, Collee JM, Tilanus-Linthorst M, Hall P, Li J, Brand JS, Humphreys K, Cox A, Reed MW, Luccarini C, Baynes C, Dunning AM, Hamann U, Torres D, Ulmer HU, Rudiger T, Jakubowska A, Lubinski J, Jaworska K, Durda K, Slager S, Toland AE, Ambrosone CB, Yannoukakos D, Swerdlow A, Ashworth A, Orr N, Jones M, Gonzalez-Neira A, Pita G, Alonso MR, Alvarez N, Herrero D, Tessier DC, Vincent D, Bacot F, Simard J, Dumont M, Soucy P, Eeles R, Muir K, Wiklund F, Gronberg H, Schleutker J, Nordestgaard BG, Weischer M, Travis RC, Neal D, Donovan JL, Hamdy FC, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Schaid DJ, Kelley JL, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Butterbach K, Park J, Kaneva R, Batra J, Teixeira MR, Kote-Jarai Z, Olama AA, Benlloch S, Renner SP, Hartmann A, Hein A, Ruebner M, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambretchs S, Doherty JA, Rossing MA, Nickels S, Eilber U, Wang-Gohrke S, Odunsi K, Sucheston-Campbell LE, Friel G, Lurie G, Killeen JL, Wilkens LR, Goodman MT, Runnebaum I, Hillemanns PA, Pelttari LM, Butzow R, Modugno F, Edwards RP, Ness RB, Moysich KB, du Bois A, Heitz F, Harter P, Kommoss S, Karlan BY, Walsh C, Lester J, Jensen A, Kjaer SK, Hogdall E, Peissel B, Bonanni B, Bernard L, Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Larson MC, Fogarty ZC, Kalli KR, Liang D, Lu KH, Hildebrandt MA, Wu X, Levine DA, Dao F, Bisogna M, Berchuck A, Iversen ES, Marks JR, Akushevich L, Cramer DW, Schildkraut J, Terry KL, Poole EM, Stampfer M, Tworoger SS, Bandera EV, Orlow I, Olson SH, Bjorge L, Salvesen HB, van Altena AM, Aben KK, Kiemeney LA, Massuger LF, Pejovic T, Bean Y, Brooks-Wilson A, Kelemen LE, Cook LS, Le ND, Gorski B, Gronwald J, Menkiszak J, Hogdall CK, Lundvall L, Nedergaard L, Engelholm SA, Dicks E, Tyrer J, Campbell I, McNeish I, Paul J, Siddiqui N, Glasspool R, Whittemore AS, Rothstein JH, McGuire V, Sieh W, Cai H, Shu XO, Teten RT, Sutphen R, McLaughlin JR, Narod SA, Phelan CM, Monteiro AN, Fenstermacher D, Lin HY, Permuth JB, Sellers TA, Chen YA, Tsai YY, Chen Z, Gentry-Maharaj A, Gayther SA, Ramus SJ, Menon U, Wu AH, Pearce CL, Van Den Berg D, Pike MC, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Moes-Sosnowska J, Kupryjanczyk J, Pharoah PD, Song H, Winship I, Chenevix-Trench G, Giles GG, Tavtigian SV, Easton DF, Milne RL (2016). PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet, 53(12), 800-811.
  143. Goldstein AM, Chan M, Harland M, Hayward NK, Demenais F, Bishop DT, Azizi E, Bergman W, Bianchi-Scarra G, Bruno W, Calista D, Albright LA, Chaudru V, Chompret A, Cuellar F, Elder DE, Ghiorzo P, Gillanders EM, Gruis NA, Hansson J, Hogg D, Holland EA, Kanetsky PA, Kefford RF, Landi MT, Lang J, Leachman SA, MacKie RM, Magnusson V, Mann GJ, Bishop JN, Palmer JM, Puig S, Puig-Butille JA, Stark M, Tsao H, Tucker MA, Whitaker L, Yakobson E, Lund Melanoma Study Group, Melanoma Genetics Consortium (GenoMEL). (2007). Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet, 44(2), 99-106.
  144. Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D, Bishop DT, Carey J, Kivlin J, Willard H, Nakamura Y, O'Connell P, Leppert M, White R, Skolnick MH. (1987). A genomic search for linkage of neurofibromatosis to RFLPs. J Med Genet, 24(9), 536-8.
  145. Goldgar DE, Cannon-Albright LA, Meyer LJ, Piepkorn MW, Zone JJ, Skolnick MH (1991). Inheritance of nevus number and size in melanoma and dysplastic nevus syndrome kindreds. J Natl Cancer Inst, 83(23), 1726-33.
  146. Ward JH, Marshall CJ, Schumann GB, Hogle H, Cannon-Albright LA, McWhorter WP, Eyre HJ, Skolnick MH (1990). Detection of proliferative breast disease by four-quadrant, fine-needle aspiration. J Natl Cancer Inst, 82(11), 964-6.
  147. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994). Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst, 86(21), 1600-8.
  148. Goldgar DE, Fields P, Lewis CM, Tran TD, Cannon-Albright LA, Ward JH, Swensen J, Skolnick MH (1994). A large kindred with 17q-linked breast and ovarian cancer: genetic, phenotypic, and genealogical analysis. J Natl Cancer Inst, 86(3), 200-9.
  149. Rebbeck TR, Levin AM, Eisen A, Snyder C, Watson P, Cannon-Albright L, Isaacs C, Olopade O, Garber JE, Godwin AK, Daly MB, Narod SA, Neuhausen SL, Lynch HT, Weber BL (1999). Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. J Natl Cancer Inst, 91(17), 1475-9.
  150. Teerlink CC, Huff C, Stevens J, Yu Y, Holmen SL, Silvis MR, Trombetti K, Zhao H, Grossman D, Farnham JM, Wen J, Facelli JC, Thomas A, Babst M, Florell SR, Meyer L, Zone JJ, Leachman S, Cannon-Albright LA (2018). A Nonsynonymous Variant in the GOLM1 Gene in Cutaneous Malignant Melanoma. J Natl Cancer Inst, 110(12), 1380-1385.
  151. Breast Cancer Linkage Consortium, Cannon-Albright LA (1999). Cancer risks in BRCA2 mutation carriers. J Natl Cancer Inst, 91, 1310-1316.
  152. Thompson D, Easton D, on behalf of the Breast Cancer Linkage Consortium (2002). Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst, Sep 18:94(18), 1358-1365.
  153. Pelt CE, Erickson JA, Peters CL, Anderson MB, Cannon-Albright L (2015). A Heritable Predisposition to Osteoarthritis of the Hip. J Arthroplasty, 30(9 Suppl), 125-9.
  154. Florell SR, Boucher KM, Garibotti G, Astle J, Kerber R, Mineau G, Wiggins C, Noyes RD, Tsodikov A, Cannon-Albright LA, Zone JJ, Samlowski WE, Leachman SA (2005). Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol, 23(28), 7168-77.
  155. Cannon Albright LA, Camp NJ, Farnham JM, MacDonald J, Abtin K, Rowe KG (2003). A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg, 99(4), 637-43.
  156. Cannon-Albright LA (2008). Detection of aneurysms. J Neurosurg, 108(6), 1130-1.
  157. Couldwell WT, Cannon-Albright LA (2014). Co-prevalence of other tumors in patients harboring pituitary tumors. J Neurosurg, 121(6), 1474-7.
  158. Abbott D, Brockmeyer D, Neklason DW, Teerlink C, Cannon-Albright LA (2017). Population-based description of familial clustering of Chiari malformation Type I. J Neurosurg, 128(2), 460-465.
  159. Lewis C, Book L, Black J, Sawitzke A, Cannon-Albright LA, Zone J, Neuhausen S (2000). Celiac Disease and human leukocyte antigen genotype: Accuracy of diagnosis in self-diagnosed individuals, dosage effect and sibling risk. J Pediatr Gastroenterol Nutr, 31 (1), 22-27.
  160. Teerlink CC, Bernhisel R, Cannon-Albright LA, Rollins MD (2017). A population-based description of familial clustering of Hirschsprung disease. J Pediatr Surg, 53(7), 1355-1359.
  161. McWhorter WP, Hernandez AD, Meikle AW, Terreros DA, Smith JA Jr, Skolnick MH, Cannon-Albright LA, Eyre HJ (1992). A screening study of prostate cancer in high risk families. J Urol, 148(3), 826-8.
  162. Agarwal N, Alex AB, Farnham JM, Patel S, Gill D, Buckley TH, Stephenson RA, Cannon-Albright L (2016). Inherited variants in SULT1E1 and response to abiraterone acetate in men with metastatic castration refractory prostate cancer (mCRPC).LID - S0022-5347(16)30328-7 [pii]LID - 10.1016/j.juro.2016.04.079 [doi]. J Urol, 196(4), 1112-6.
  163. Shattuck-Eidens D, Oliphant A, McClure M, McBride C, Gupte J, Rubano T, Pruss D, Tavtigian SV, Teng DH-F, Adey N, Staebell M, Gumpper K, Lundstrom R, Hulick M, Kelly M, Holmen J, Lingenfelter B, Manley S, Fujimura F, Luce M, Ward B, Cannon-Albright LA, Steele L, Offit K, Gilewski T, Norton L, Brown K, Schultz C, Hampel H, Schluger A, Giulotto E, Zoli W, Raviaoli A, Nevanlinna NH, Pyrhonen S, Rowley P, oader s, Osborne MP, Daly M, Tepler I, Weinstein PL, Scalia JL, Michaelson R, Scott RJ, Radice P, Pierotti MA, Garber JE, Isaacs C, Peshkin B, Lippman ME, Dosik MH, Caligo MA, Greenstein RM, Pilarski R, Weber B, Burgemeister R, Frank TS, Skolnick MH, Thomas A (1997). BRCA1 sequence analysis in women in high risk for susceptibility mutations. JAMA, 278, 1242-1250.
  164. Scholand MB, Coon H, Wolff R, Cannon-Albright L (2013). Use of a genealogical database demonstrates heritability of pulmonary fibrosis. Lung, 191(5), 475-81.
  165. Johnson NE, Abbott D, Cannon-Albright LA (2015). Relative risks for comorbidities associated with myotonic dystrophy: A population-based analysis. Muscle Nerve, 52(4), 659-61.
  166. Abbott D, Johnson NE, Cannon-Albright LA (2016). A population-based survey of risk for cancer in individuals diagnosed with myotonic dystrophy. Muscle Nerve, 54(4), 783-5.
  167. Cannon-Albright LA, Skolnick MH, Bishop DT, Lee RG, Burt RW (1988). Common inheritance of susceptibility to colonic adenomatous polyps and associated colorectal cancers. N Engl J Med, 319(9), 533-7.
  168. Camp NJ, Werner TL, Cannon-Albright LA (2008). Familial myeloma. N Engl J Med, 359(16), 1734-5; author reply 1735.
  169. Burt RW, Bishop DT, Cannon LA, Dowdle MA, Lee RG, Skolnick MH: (1985). Dominant inheritance of adenomatous polyps and colorectal cancer. N Engl J Med, 312, 1540-1544.
  170. Blumenthal DT, Cannon-Albright LA (2008). Familiality in brain tumors. Neurology, 71(13), 1015-20.
  171. Gibson SB, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L (2014). Familial clustering of ALS in a population-based resource. Neurology, 82(1), 17-22.
  172. Gibson SB, Abbott D, Farnham JM, Thai KK, McLean H, Figueroa KP, Bromberg MB, Pulst SM, Cannon-Albright L (2016). Population-based risks for cancer in patients with ALS.LID - 10.1212/WNL.0000000000002757 [pii]. Neurology, 87(3), 289-94.
  173. Allen-Brady K, Cannon-Albright L, Farnham JM, Teerlink C, Vierhout ME, van Kempen LC, Kluivers KB, Norton PA (2011). Identification of six loci associated with pelvic organ prolapse using genome-wide association analysis. Obstet Gynecol, 118(6), 1345-53.
  174. Stone S, Dayananth P, Jiang P, Weaver-Feldhaus JM, Tavtigian SV, Cannon-Albright LA, Kamb A. (1995). Genomic structure, expression and mutational analysis of the P15 (MTS2) gene. Oncogene, 11, 987-991.
  175. Camp NJ, Farnham JM, Cannon Albright LA (2005). Genomic search for prostate cancer predisposition loci in Utah pedigrees. Prostate, 65(4), 365-74.
  176. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA (2007). Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees. Prostate, 67(6), 605-13.
  177. Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright LA (2007). Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb. Prostate, 67(13), 1456-64.
  178. Christensen GB, Baffoe-Bonnie AB, George A, Powell I, Bailey-Wilson JE, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Xu J, Stanford JL, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Isaacs WB, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Lange EM, Cooney KA, Tammela TL, Schleutker J, Paiss T, Maier C, Grönberg H, Wiklund F, Emanuelsson M, Farnham JM, Cannon-Albright LA, Camp NJ, International Consortium for Prostate Cancer Genetics. (2010). Genome-wide linkage analysis of 1,233 prostate cancer pedigrees from the International Consortium for Prostate Cancer Genetics using novel sumLINK and sumLOD analyses. Prostate, 70(7), 735-44.
  179. Lu L, Cancel-Tassin G, Valeri A, Cussenot O, Lange EM, Cooney KA, Farnham JM, Camp NJ, Cannon-Albright LA, Tammela TL, Schleutker J, Hoegel J, Herkommer K, Maier C, Vogel W, Wiklund F, Emanuelsson M, Gronberg H, Wiley KE, Isaacs SD, Walsh PC, Helfand BT, Kan D, Catalona WJ, Stanford JL, FitzGerald LM, Johanneson B, Deutsch K, McIntosh L, Ostrander EA, Thibodeau SN, McDonnell SK, Hebbring S, Schaid DJ, Whittemore AS, Oakley-Girvan I, Hsieh CL, Powell I, Bailey-Wilson JE, Cropp CD, Simpson C, Carpten JD, Seminara D, Zheng SL, Xu J, Giles GG, Severi G, Hopper JL, English DR, Foulkes WD, Maehle L, Moller P, Badzioch MD, Edwards S, Guy M, Eeles R, Easton D, Isaacs WB (2012). Chromosomes 4 and 8 implicated in a genome wide SNP linkage scan of 762 prostate cancer families collected by the ICPCG. Prostate, 72(4), 410-26.
  180. Cannon-Albright LA, Farnham JM, Bailey M, Albright FS, Teerlink CC, Agarwal N, Stephenson RA, Thomas A (2014). Identification of specific Y chromosomes associated with increased prostate cancer risk. Prostate, 74(9), 991-8.
  181. Szulkin R, Whitington T, Eklund M, Aly M, Eeles RA, Easton D, Kote-Jarai ZS, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Henderson BE, Schumacher F, Haiman CA, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Lubinski J, Kluzniak W, Cannon-Albright L, Brenner H, Butterbach K, Stegmaier C, Park JY, Sellers T, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Clements JA, Spurdle A, Teixeira MR, Paulo P, Maia S, Pandha H, Michael A, Kierzek A, Gronberg H, Wiklund F (2015). Prediction of individual genetic risk to prostate cancer using a polygenic score. Prostate, 75(13), 1467-74.
  182. Albright FS, Stephenson RA, Agarwal N, Cannon-Albright LA (2016). Relative Risks for Lethal Prostate Cancer Based on Complete Family History of Prostate Cancer Death. Prostate, 77(1), 41-48.
  183. Cannon-Albright LA, Schwab A, Camp NJ, Farnham JS, Thomas A (2005). Population-based Risk Assessment for Other Cancers in Relatives of Hereditary Prostate Cancer (HPC) Cases. Prostate, 64(4), 347-355.
  184. Schaid DJ, Chang BL, Cannon-Albright LA, and the International Consortium for Prostate cancer Genetics (2005). Description of the International Consortium for Prostate Cancer Genetics, and Failure to Replicate Linkage of Hereditary Prostate Cancer to 20q13. Prostate, 63(3), 276-90.
  185. Albright F, Stephenson RA, Agarwal N, Teerlink CC, Lowrance WT, Farnham JM, Cannon-Albright LA (2015). Prostate cancer risk prediction based on complete prostate cancer family history. Prostate, 75(4), 390-8.
  186. Meyer LJ, Piepkorn MA, Seuchter SA, Cannon-Albright LA, Bishop DT, Zone JJ, Skolnick MH. (1988). Genetic and epidemiologic evaluation of dysplastic nevi. Pigment Cell Res, 1(Supple), 144-151.
  187. Burt RW, Bishop DT, Lee RG, Cannon-Albright LA, Skolnick MH (1988). Inheritance of colonic adenomatous polyps and colorectal cancer. Prog Clin Biol Res, 279, 189-94.
  188. Gaffney DK, Brohet RM, Lewis CM, Holden JA, Buys SS, Neuhausen SL, Steele L, Avizonis V, Stewart JR, Cannon-Albright LA (1998). Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations. Radiother Oncol, 47(2), 129-36.
  189. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE (1992). Assignment of a locus for familial melanoma, MLM, to chromosome 9p13-p22. Science, 258(5085), 1148-52.
  190. Skolnick MH, Cannon-Albright LA, Goldgar DE, Ward JH, Marshall CJ, Schumann GB, Hogle H, McWhorter WP, Wright EC, Tran TD (1990). Inheritance of proliferative breast disease in breast cancer kindreds. Science, 250(4988), 1715-20.
  191. Barker D, Wright E, Nguyen K, Cannon L, Fain P, Goldgar D, Bishop DT, Carey J, Livlin J, Willard H, Nakamura Y, O'Connell P, Leppert M, White R, Skolnick MH. (1987). Gene for Von Recklinhausen neuro-fibramatosis is in the pericentromeric region of Chromosome 17. Science, 236, 1100-1102.
  192. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright LA, Goldgar D, Wiseman R, Kamb A, Skolnick MH. (1994). A Strong Candidate for the Breast and Ovarian Cancer susceptibility Gene BRCA 1. Science, 266, 66-71.
  193. Wooster R, Neuhausen S, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod S, Lenoir G, Lynch H, Feunteun J, Devilee P, Cornelisse CJ, Menko FH, Daly PA, Ormiston W, McManus R, Pye C, Lewis C, Cannon-Albright LA, Peto J, Ponder BAJ, Skolnick MH, Easton DF, Goldgar DE, Stratton MR. (1994). Localization of a breast cancer susceptibility gene (BRCA2) to chromosome 13q12-13. Science, 265, 2088-2090.
  194. Skolnick MH, Marshall CJ, McWhorter W, Goldgar D, Cannon-Albright LA, Ward JH, Eyre H. (1991). Proliferative breast disease: Diagnosis and implications. Science, 253(5022), 915-916.
  195. Cannon-Albright LA, Skolnick MH (1996). The genetics of familial breast cancer. Semin Oncol, 23(Suppl 2), 1-5.
  196. Patel AA, Spiker WR, Daubs M, Brodke DS, Cannon-Albright LA (2012). Evidence of an inherited predisposition for cervical spondylotic myelopathy. Spine (Phila Pa 1976), 37(1), 26-9.
  197. Berthelemy-Okazaki N, Zhao Y, Yang Z, Camp NJ, Farnham J, Parker D, Tsuruda J, Macdonald J, Zhang K, Cannon-Albright LA (2005). Examination of ELN as a candidate gene in the Utah intracranial aneurysm pedigrees. Stroke, 36(6), 1283-4.
  198. Carr SR, Akerley W, Hashibe M, Cannon-Albright LA (2015). Evidence for a genetical contribution to non-smoking-related lung cancer. Thorax, 70(11), 1033-9.
  199. Teerlink CC, Hegewald MJ, Cannon-Albright LA (2007). A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med, 176(9), 865-70.
  200. Teerlink CC, Camp NJ, Bansal A, Crapo R, Hughes D, Kort E, Rowe K, Cannon-Albright LA (2009). Significant evidence for linkage to chromosome 5q13 in a genome-wide scan for asthma in an extended pedigree resource. Eur J Hum Genet, 17(5), 636-43.
  201. Cai Z, Camp NJ, Cannon-Albright L, Thomas A (2011). Identification of regions of positive selection using Shared Genomic Segment analysis. Eur J Hum Genet, 19(6), 667-71.
  202. Weires MB, Tausch B, Haug PJ, Edwards CQ, Wetter T, Cannon-Albright LA (2007). Familiality of diabetes mellitus. Exp Clin Endocrinol Diabetes, 115(10), 634-40.
  203. Teerlink CC, Cannon-Albright LA, Tashjian RZ (2015). Significant association of full-thickness rotator cuff tears and estrogen-related receptor-ß (ESRRB). J Shoulder Elbow Surg, 24(2), e31-5.
  204. Tashjian RZ, Granger EK, Farnham JM, Cannon-Albright LA, Teerlink CC (2016). Genome-wide association study for rotator cuff tears identifies two significant single-nucleotide polymorphisms. J Shoulder Elbow Surg, 25(2), 174-9.
  205. Tashjian RZ, Granger EK, Zhang Y, Teerlink CC, Cannon-Albright LA (2016). Identification of a genetic variant associated with rotator cuff repair healing. J Shoulder Elbow Surg, 25(6), 865-72.
  206. Bender JM, Ampofo K, Sheng X, Pavia AT, Cannon-Albright L, Byington CL (2009). Parapneumonic empyema deaths during past century, Utah. Emerg Infect Dis, 15(1), 44-8.
  207. Lin HY, Chen DT, Huang PY, Liu YH, Ochoa A, Zabaleta J, Mercante DE, Fang Z, Sellers TA, Pow-Sang JM, Cheng CH, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Hamdy F, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Batra J, Teixeira MR, Pandha H, Lu YJ, Park JY (2017). SNP interaction pattern identifier (SIPI): an intensive search for SNP-SNP interaction patterns. Bioinformatics, 33(6), 822-833.
  208. Lee JP, Hopf HW, Cannon-Albright L (2013). Empiric evidence for a genetic contribution to predisposition to surgical site infection. Wound repair and regeneration, 21(2), 211-5.
  209. Neklason DW, VanDerslice J, Curtin K, Cannon-Albright L (2016). Evidence for a heritable contribution to neuroendocrine tumors of the small intestine. Endocrine-related cancer, 23(2), 93-100.
  210. Deffenbaugh AM, Frank TS, Hoffman M, Cannon-Albright L, Neuhausen S (2002). Characterization of common BRCA1 and BRCA2 variants. Genetic testing, 6(2), 119-21.
  211. Bansal A, Hughes DC, Farnham JM, Bagi CM, O'Neil G, Rowe K, Shakib JH, Wood GC, Wyckoff JA, Cannon-Albright L (2000). Impact of correlated factors on bone density in individuals with a family history of osteoporosis. Journal of clinical densitometry, 3(4), 333-8.
  212. Couldwell WT, Cannon-Albright L (2017). A description of familial clustering of meningiomas in the Utah population. Neuro-oncology, 19(12), 1683-1687.
  213. Jones KB, Haldar M, Schiffman JD, Cannon-Albright L, Lessnick SL, Sharma S, Capecchi MR, Randall R (2011). Of mice and men: opportunities to use genetically engineered mouse models of synovial sarcoma for preclinical cancer therapeutic evaluation. Cancer control, 18(3), 196-203.
  214. Couldwell WT, Cannon-Albright (2010). A heritable predisposition to pituitary tumors. Pituitary, 13(2), 130-7.
  215. Cai Z, Thomas A, Teerlink C, Farnham JM, Cannon-Albright LA, Camp N (2012). Pairwise shared genomic segment analysis in three Utah high-risk breast cancer pedigrees. BMC genomics, 13, 676.
  216. Bailey-Wilson JE, Childs EJ, Cropp CD, Schaid DJ, Xu J, Camp NJ, Cannon-Albright LA, Farnham JM, George A, Powell I, Carpten JD, Giles GG, Hopper JL, Severi G, English DR, Foulkes WD, Maehle L, Moller P, Eeles R, Easton D, Guy M, Edwards S, Badzioch MD, Whittemore AS, Oakley-Girvan I, Hsieh CL, Dimitrov L, Stanford JL, Karyadi DM, Deutsch K, McIntosh L, Ostrander EA, Wiley KE, Isaacs SD, Walsh PC, Thibodeau SN, McDonnell SK, Hebbring S, Lange EM, Cooney KA, Tammela TL, Schleutker J, Maier C, Bochum S, Hoegel J, Gronberg H, Wiklund F, Emanuelsson M, Cancel-Tassin G, Valeri A, Cussenot O, Isaacs W (2012). Analysis of Xq27-28 linkage in the international consortium for prostate cancer genetics (ICPCG) families. BMC medical genetics, 13(1), 46.
  217. Albright F, Light K, Light A, Bateman L, Cannon-Albright L (2011). Evidence for a heritable predisposition to Chronic Fatigue Syndrome. BMC neurology, 11, 62.
  218. Albright F, Teerlink C, Werner TL, Cannon-Albright L (2012). Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site. BMC cancer, 12, 138.
  219. Camp NJ, Cannon-Albright L (2005). Dissecting the genetic etiology of major depressive disorder using linkage analysis. Trends in molecular medicine, 11(3), 138-144.
  220. Taylor DP, Stoddard GJ, Burt RW, Williams MS, Mitchell JA, Haug PJ, Cannon-Albright L (2011). How well does family history predict who will get colorectal cancer? Implications for cancer screening and counseling. Genetics in medicine, 13(5), 385-91.
  221. Taylor DP, Cannon-Albright LA, Sweeney C, Williams MS, Haug PJ, Mitchell JA, Burt R (2011). Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genetics in medicine, 13(8), 737-43.
  222. Teerlink CC, Albright FS, Lins L, Cannon-Albright L (2012). A comprehensive survey of cancer risks in extended families. Genetics in medicine, 14(1), 107-14.
  223. Cannon-Albright LA, Dintelman S, Maness T, Backus S, Thomas A, Meyer L (2013). Creation of a national resource with linked genealogy and phenotypic data: the Veterans Genealogy Project. Genetics in medicine, 15(7), 541-7.
  224. Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, Hruban RH, Cote ML, McWilliams RR, Roberts NJ, Cannon-Albright LA, Li D, Moyes K, Wenstrup RJ, Hartman AR, Seminara D, Klein AP, Petersen G (2015). BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study. Genetics in medicine, 17(7), 569-77.
  225. Niazi TN, Cannon-Albright LA, Couldwell W (2010). Utah Population Database: a tool to study the hereditary element of nonsyndromic neurosurgical diseases. Neurosurgical focus, 28(1), E1.
  226. Barrott JJ, Zhu JF, Smith-Fry K, Susko AM, Nollner D, Burrell LD, Pozner A, Capecchi MR, Yap JT, Cannon-Albright LA, Deng X, Jones K (2017). The Influential Role of BCL2 Family Members in Synovial Sarcomagenesis. Molecular cancer research, 15(12), 1733-1740.
  227. Bonilla C, Lewis SJ, Martin RM, Donovan JL, Hamdy FC, Neal DE, Eeles R, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Pandha H, Lathrop M, Davey Smith (2016). Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort. BMC medicine, 14(1), 66.
  228. Maul JS, Burt RW, Cannon-Albright L (2007). A familial component to human rectal cancer, independent of colon cancer risk. Clinical gastroenterology and hepatology, 5(9), 1080-4.
  229. Shirts BH, Burt RW, Mulvihill SJ, Cannon-Albright L (2010). A population-based description of familial clustering of pancreatic cancer. Clinical gastroenterology and hepatology, 8(9), 812-6.
  230. Diedrich KT, Roberts JA, Schmidt RH, Albright LA, Yetman AT, Parker D (2011). Medical record and imaging evaluation to identify arterial tortuosity phenotype in populations at risk for intracranial aneurysms. AMIA ... Annual Symposium proceedings. AMIA Symposium, 2011, 295-304.
  231. Cannon-Albright LA, Farnham JM, Thomas A, Camp N (2005). Identification and study of Utah pseudo-isolate populations-prospects for gene identification. American journal of medical genetics. Part A, 137A(3), 269-75.
  232. Camp NJ, Lowry MR, Richards RL, Plenk AM, Carter C, Hensel CH, Abkevich V, Skolnick MH, Shattuck D, Rowe KG, Hughes DC, Cannon-Albright L (2005). Genome-wide Linkage Analyses of Extended Utah Pedigrees Identifies Loci that Influence Recurrent, Early-Onset Major Depression and Anxiety Disorders. American journal of medical genetics. Part B, Neuropsychiatric genetics, May 5:135(1), 85-93.
  233. Saunders EJ, Dadaev T, Leongamornlert DA, Jugurnauth-Little S, Tymrakiewicz M, Wiklund F, Al Olama AA, Benlloch S, Neal DE, Hamdy FC, Donovan JL, Giles GG, Severi G, Gronberg H, Aly M, Haiman CA, Schumacher F, Henderson BE, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock S, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Nordestgaard BG, Canzian F, Campa D, Riboli E, Key TJ, Travis RC, Ingles SA, John EM, Hayes RB, Pharoah P, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Clements JA, Teixeira MR, Xu J, Mikropoulos C, Goh C, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Easton DF, Muir K, Eeles RA, Kote-Jarai (2014). Fine-mapping the HOXB region detects common variants tagging a rare coding allele: evidence for synthetic association in prostate cancer. PLoS genetics, 10(2), e1004129.
  234. Hahn AW, Gill DM, Nussenzveig RH, Poole A, Farnham J, Cannon-Albright L, Agarwal (2018). Germline Variant in HSD3B1 (1245 A > C) and Response to Abiraterone Acetate Plus Prednisone in Men With New-Onset Metastatic Castration-Resistant Prostate Cancer.LID - S1558-7673(18)30215-5 [pii]LID - 10.1016/j.clgc.2018.03.006 [doi]. Clinical genitourinary cancer, 16(4), 288-292.
  235. Calvert GT, Randall RL, Jones KB, Cannon-Albright L, Lessnick S, Schiffman J (2012). At-risk populations for osteosarcoma: the syndromes and beyond. Sarcoma, 2012, 152382.
  236. Lin WY, Brock IW, Connley D, Cramp H, Tucker R, Slate J, Reed MW, Balasubramanian SP, Cannon-Albright LA, Camp NJ, Cox (2013). Associations of ATR and CHEK1 single nucleotide polymorphisms with breast cancer. PloS one, 8(7), e68578.
  237. Kauwe JS, Ridge PG, Foster NL, Cannon-Albright L (2013). Strong evidence for a genetic contribution to late-onset Alzheimer's disease mortality: a population-based study. PloS one, 8(10), e77087.
  238. Yates WR, Johnson C, McKee P, Cannon-Albright L (2013). Genetic analysis of low BMI phenotype in the Utah Population Database. PloS one, 8(12), e80287.
  239. Allen-Brady K, Farnham J, Cannon-Albright (2011). Strategies for selection of subjects for sequencing after detection of a linkage peak. BMC proceedings, 5 Suppl 9(Suppl 9 Genetic Analysis Workshop 17: Unraveling Human Exome DataS Ghosh, H Bickeboller, J Bailey, JE Bailey-Wilson, R Cantor, W Daw, AL DeStefano, CD Engelman, A Hinrichs, J Houwing-Duistermaat, IR Konig, J Kent Jr., N Pankratz, A Paterson, E Pugh, Y Su), S77.
  240. Christensen GB, Cannon-Albright LA, Thomas A, Camp N (2007). Extracting Disease Risk Profiles from Expression Data for Linkage Analysis: Application to Prostate Cancer. BMC proceedings, Suppl(1), S82.
  241. Allen-Brady K, Farnham JM, Camp NJ, Karlins E, Ostrander EA, Cannon-Albright L (2009). No evidence of BRCA2 mutations in chromosome 13q-linked Utah high-risk prostate cancer pedigrees. BMC research notes, 2, 94.
  242. Cannon-Albright LA, Cooper KG, Georgelas A, Bernard P (2011). High quality and quantity Genome-wide germline genotypes from FFPE normal tissue. BMC research notes, 4, 159.
  243. Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW, Gonzalez Murcia JD, Farnham JM, Damato AR, Allen M, Wang X, Harari O, Fernandez VM, Guerreiro R, Bras J, Hardy J, Munger R, Norton M, Sassi C, Singleton A, Younkin SG, Dickson DW, Golde TE, Price ND, Ertekin-Taner N, Cruchaga C, Goate AM, Corcoran C, Tschanz J, Cannon-Albright LA, Kauwe JSK, Alzheimer's Disease Neuroimaging Initiative (2017). Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience. Genome medicine, 9(1), 100.
  244. Ridge PG, Karch CM, Hsu S, Arano I, Teerlink CC, Ebbert MTW, Murcia JDG, Farnham JM, Damato AR, Allen M, Wang X, Harari O, Fernandez VM, Guerreiro R, Bras J, Hardy J, Munger R, Norton M, Sassi C, Singleton A, Younkin SG, Dickson DW, Golde TE, Price ND, Ertekin-Taner N, Cruchaga C, Goate AM, Corcoran C, Tschanz J, Cannon-Albright LA, Kauwe JSK, Alzheimer's Disease Neuroimaging Initiative (2018). Correction to: Linkage, whole genome sequence, and biological data implicate variants in RAB10 in Alzheimer's disease resilience. Genome medicine, 10(1), 4.
  245. Randall RL, Lessnick SL, Jones KB, Gouw LG, Cummings JE, Cannon-Albright L, Schiffman J (2010). Is There a Predisposition Gene for Ewing's Sarcoma?. Journal of oncology, 2010, 397632.
  246. Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzi'ski M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Vangsted AJ, W'tek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon (2015). Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nature communications, 6, 7539.
  247. Ziv E, Dean E, Hu D, Martino A, Serie D, Curtin K, Campa D, Aftab B, Bracci P, Buda G, Zhao Y, Caswell-Jin J, Diasio R, Dumontet C, Dudzinski M, Fejerman L, Greenberg A, Huntsman S, Jamroziak K, Jurczyszyn A, Kumar S, Atanackovic D, Glenn M, Cannon-Albright LA, Jones B, Lee A, Marques H, Martin T, Martinez-Lopez J, Rajkumar V, Sainz J, Juul Vangsted A, Watek M, Wolf J, Slager S, Camp NJ, Canzian F, Vachon (2015). Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients. Nature communications, 6, 10203.
  248. Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, Nieters A, Kelly RS, Smedby KE, Monnereau A, Cozen W, Cox A, Wang SS, Lan Q, Teras LR, Machado M, Yeager M, Brooks-Wilson AR, Hartge P, Purdue MP, Birmann BM, Vajdic CM, Cocco P, Zhang Y, Giles GG, Zeleniuch-Jacquotte A, Lawrence C, Montalvan R, Burdett L, Hutchinson A, Ye Y, Call TG, Shanafelt TD, Novak AJ, Kay NE, Liebow M, Cunningham JM, Allmer C, Hjalgrim H, Adami HO, Melbye M, Glimelius B, Chang ET, Glenn M, Curtin K, Cannon-Albright LA, Diver WR, Link BK, Weiner GJ, Conde L, Bracci PM, Riby J, Arnett DK, Zhi D, Leach JM, Holly EA, Jackson RD, Tinker LF, Benavente Y, Sala N, Casabonne D, Becker N, Boffetta P, Brennan P, Foretova L, Maynadie M, McKay J, Staines A, Chaffee KG, Achenbach SJ, Vachon CM, Goldin LR, Strom SS, Leis JF, Weinberg JB, Caporaso NE, Norman AD, De Roos AJ, Morton LM, Severson RK, Riboli E, Vineis P, Kaaks R, Masala G, Weiderpass E, Chirlaque MD, Vermeulen RCH, Travis RC, Southey MC, Milne RL, Albanes D, Virtamo J, Weinstein S, Clavel J, Zheng T, Holford TR, Villano DJ, Maria A, Spinelli JJ, Gascoyne RD, Connors JM, Bertrand KA, Giovannucci E, Kraft P, Kricker A, Turner J, Ennas MG, Ferri GM, Miligi L, Liang L, Ma B, Huang J, Crouch S, Park JH, Chatterjee N, North KE, Snowden JA, Wright J, Fraumeni JF, Offit K, Wu X, de Sanjose S, Cerhan JR, Chanock SJ, Rothman N, Slager S (2016). Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nature communications, 7, 10933.
  249. Gusev A, Shi H, Kichaev G, Pomerantz M, Li F, Long HW, Ingles SA, Kittles RA, Strom SS, Rybicki BA, Nemesure B, Isaacs WB, Zheng W, Pettaway CA, Yeboah ED, Tettey Y, Biritwum RB, Adjei AA, Tay E, Truelove A, Niwa S, Chokkalingam AP, John EM, Murphy AB, Signorello LB, Carpten J, Leske MC, Wu SY, Hennis AJ, Neslund-Dudas C, Hsing AW, Chu L, Goodman PJ, Klein EA, Witte JS, Casey G, Kaggwa S, Cook MB, Stram DO, Blot WJ, Eeles RA, Easton D, Kote-Jarai Z, Al Olama AA, Benlloch S, Muir K, Giles GG, Southey MC, Fitzgerald LM, Gronberg H, Wiklund F, Aly M, Henderson BE, Schleutker J, Wahlfors T, Tammela TL, Nordestgaard BG, Key TJ, Travis RC, Neal DE, Donovan JL, Hamdy FC, Pharoah P, Pashayan N, Khaw KT, Stanford JL, Thibodeau SN, McDonnell SK, Schaid DJ, Maier C, Vogel W, Luedeke M, Herkommer K, Kibel AS, Cybulski C, Wokolorczyk D, Kluzniak W, Cannon-Albright L, Teerlink C, Brenner H, Dieffenbach AK, Arndt V, Park JY, Sellers TA, Lin HY, Slavov C, Kaneva R, Mitev V, Batra J, Spurdle A, Clements JA, Teixeira MR, Pandha H, Michael A, Paulo P, Maia S, Kierzek A, Conti DV, Albanes D, Berg C, Berndt SI, Campa D, Crawford ED, Diver WR, Gapstur SM, Gaziano JM, Giovannucci E, Hoover R, Hunter DJ, Johansson M, Kraft P, Le Marchand L, Lindstrom S, Navarro C, Overvad K, Riboli E, Siddiq A, Stevens VL, Trichopoulos D, Vineis P, Yeager M, Trynka G, Raychaudhuri S, Schumacher FR, Price AL, Freedman ML, Haiman CA, Pasaniuc (2016). Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nature communications, 7, 10979.
  250. Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, PRACTICAL Consortium, Ziogas A, Zheng W, Yang HP, Wu AH, Wozniak EL, Woo YL, Winterhoff B, Wik E, Whittemore AS, Wentzensen N, Weber RP, Vitonis AF, Vincent D, Vierkant RA, Vergote I, Van Den Berg D, Van Altena AM, Tworoger SS, Thompson PJ, Tessier DC, Terry KL, Teo SH, Templeman C, Stram DO, Southey MC, Sieh W, Siddiqui N, Shvetsov YB, Shu XO, Shridhar V, Wang-Gohrke S, Severi G, Schwaab I, Salvesen HB, Rzepecka IK, Runnebaum IB, Rossing MA, Rodriguez-Rodriguez L, Risch HA, Renner SP, Poole EM, Pike MC, Phelan CM, Pelttari LM, Pejovic T, Paul J, Orlow I, Omar SZ, Olson SH, Odunsi K, Nickels S, Nevanlinna H, Ness RB, Narod SA, Nakanishi T, Moysich KB, Monteiro AN, Moes-Sosnowska J, Modugno F, Menon U, McLaughlin JR, McGuire V, Matsuo K, Adenan NA, Massuger LF, Lurie G, Lundvall L, Lubi'ski J, Lissowska J, Levine DA, Leminen A, Lee AW, Le ND, Lambrechts S, Lambrechts D, Kupryjanczyk J, Krakstad C, Konecny GE, Kjaer SK, Kiemeney LA, Kelemen LE, Keeney GL, Karlan BY, Karevan R, Kalli KR, Kajiyama H, Ji BT, Jensen A, Jakubowska A, Iversen E, Hosono S, Høgdall CK, Høgdall E, Hoatlin M, Hillemanns P, Heitz F, Hein R, Harter P, Halle MK, Hall P, Gronwald J, Gore M, Goodman MT, Giles GG, Gentry-Maharaj A, Garcia-Closas M, Flanagan JM, Fasching PA, Ekici AB, Edwards R, Eccles D, Easton DF, Dürst M, du Bois A, Dörk T, Doherty JA, Despierre E, Dansonka-Mieszkowska A, Cybulski C, Cramer DW, Cook LS, Chen X, Charbonneau B, Chang-Claude J, Campbell I, Butzow R, Bunker CH, Brueggmann D, Brown R, Brooks-Wilson A, Brinton LA, Bogdanova N, Block MS, Benjamin E, Beesley J, Beckmann MW, Bandera EV, Baglietto L, Bacot F, Armasu SM, Antonenkova N, Anton-Culver H, Aben KK, Liang D, Wu X, Lu K, Hildebrandt MA, Australian Ovarian Cancer Study Group, Australian Cancer Study, Schildkraut JM, Sellers TA, Huntsman D, Berchuck A, Chenevix-Trench G, Gayther SA, Pharoah PD, Laird PW, Goode EL, Pearce C (2013). Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature communications, 4, 1628.
  251. Teerlink C, Nelson Q, Burt R, Cannon-Albright (2014). Significant evidence of linkage for a gene predisposing to colorectal cancer and multiple primary cancers on 22q11. Clinical and translational gastroenterology, 5, e50.
  252. Teerlink C, Nelson Q, Burt R, Cannon-Albright L (2014). Analysis of high-risk pedigrees identifies significant evidence for linkage for a predisposition gene for colorectal cancer and multiple primary cancers on chromosome 22q11. Clinical and translational gastroenterology, 5, e50.
  253. Allen-Brady K, Norton PA, Cannon-Albright (2015). Risk of associated conditions in relatives of subjects with interstitial cystitis. Female pelvic medicine & reconstructive surgery, 21(2), 93-8.
  254. Nelson Q, Agarwal N, Stephenson R, Cannon-Albright L (2013). A population-based analysis of clustering identifies a strong genetic contribution to lethal prostate cancer. Frontiers in genetics, 4, 152.
  255. Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin HY, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pharoah P, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeira MR, Spurdle AB, Clements JA, Park JY, Batra (2015). A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer. Cancer discovery, 5(4), 368-79.
  256. Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, Gentry-Maharaj A, Whittemore AS, Wolk A, Monteiro A, Peixoto A, Kierzek A, Cox A, Rudolph A, Gonzalez-Neira A, Wu AH, Lindblom A, Swerdlow A, Ziogas A, Ekici AB, Burwinkel B, Karlan BY, Nordestgaard BG, Blomqvist C, Phelan C, McLean C, Pearce CL, Vachon C, Cybulski C, Slavov C, Stegmaier C, Maier C, Ambrosone CB, Hogdall CK, Teerlink CC, Kang D, Tessier DC, Schaid DJ, Stram DO, Cramer DW, Neal DE, Eccles D, Flesch-Janys D, Edwards DR, Wokozorczyk D, Levine DA, Yannoukakos D, Sawyer EJ, Bandera EV, Poole EM, Goode EL, Khusnutdinova E, Hogdall E, Song F, Bruinsma F, Heitz F, Modugno F, Hamdy FC, Wiklund F, Giles GG, Olsson H, Wildiers H, Ulmer HU, Pandha H, Risch HA, Darabi H, Salvesen HB, Nevanlinna H, Gronberg H, Brenner H, Brauch H, Anton-Culver H, Song H, Lim HY, McNeish I, Campbell I, Vergote I, Gronwald J, Lubinski J, Stanford JL, Benitez J, Doherty JA, Permuth JB, Chang-Claude J, Donovan JL, Dennis J, Schildkraut JM, Schleutker J, Hopper JL, Kupryjanczyk J, Park JY, Figueroa J, Clements JA, Knight JA, Peto J, Cunningham JM, Pow-Sang J, Batra J, Czene K, Lu KH, Herkommer K, Khaw KT, Matsuo K, Muir K, Offitt K, Chen K, Moysich KB, Aittomaki K, Odunsi K, Kiemeney LA, Massuger LF, Fitzgerald LM, Cook LS, Cannon-Albright L, Hooning MJ, Pike MC, Bolla MK, Luedeke M, Teixeira MR, Goodman MT, Schmidt MK, Riggan M, Aly M, Rossing MA, Beckmann MW, Moisse M, Sanderson M, Southey MC, Jones M, Lush M, Hildebrandt MA, Hou MF, Schoemaker MJ, Garcia-Closas M, Bogdanova N, Rahman N, Le ND, Orr N, Wentzensen N, Pashayan N, Peterlongo P, Guenel P, Brennan P, Paulo P, Webb PM, Broberg P, Fasching PA, Devilee P, Wang Q, Cai Q, Li Q, Kaneva R, Butzow R, Kopperud RK, Schmutzler RK, Stephenson RA, MacInnis RJ, Hoover RN, Winqvist R, Ness R, Milne RL, Travis RC, Benlloch S, Olson SH, McDonnell SK, Tworoger SS, Maia S, Berndt S, Lee SC, Teo SH, Thibodeau SN, Bojesen SE, Gapstur SM, Kjaer SK, Pejovic T, Tammela TL, Dork T, Bruning T, Wahlfors T, Key TJ, Edwards TL, Menon U, Hamann U, Mitev V, Kosma VM, Setiawan VW, Kristensen V, Arndt V, Vogel W, Zheng W, Sieh W, Blot WJ, Kluzniak W, Shu XO, Gao YT, Schumacher F, Freedman ML, Berchuck A, Dunning AM, Simard J, Haiman CA, Spurdle A, Sellers TA, Hunter DJ, Henderson BE, Kraft P, Chanock SJ, Couch FJ, Hall P, Gayther SA, Easton DF, Chenevix-Trench G, Eeles R, Pharoah PD, Lambrechts (2016). Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer discovery, 6(9), 1052-67.
  257. Norton PA, Allen-Brady K, Cannon-Albright L (2013). The familiality of pelvic organ prolapse in the Utah Population Database. International urogynecology journal, 24(3), 413-8.
  258. Norton PA, Allen-Brady K, Wu J, Egger M, Cannon-Albright (2015). Clinical characteristics of women with familial pelvic floor disorders. International urogynecology journal, 26(3), 401-6.
  259. Hawkes JE, Campbell J, Garvin D, Cannon-Albright L, Cassidy P, Leachman S (2013). Lack of GNAQ and GNA11 Germ-Line Mutations in Familial Melanoma Pedigrees with Uveal Melanoma or Blue Nevi. Frontiers in oncology, 3, 160.
  260. Carlquist JF, McKinney JT, Horne BD, Camp NJ, Cannon-Albright L, Muhlestein JB, Hopkins P, Clarke JL, Mower CP, Park JJ, Nicholas ZP, Huntinghouse JA, Anderson J (2011). Common Variants in 6 Lipid-Related Genes Discovered by High-Resolution DNA Melting Analysis and Their Association with Plasma Lipids.LID - 2155-9880-2-138 [pii]. Journal of clinical & experimental cardiology, 2(138),
  261. Bull CJ, Bonilla C, Holly JM, Perks CM, Davies N, Haycock P, Yu OH, Richards JB, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, MacInnis RJ, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pashayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park J, Kaneva R, Batra J, Teixeira MR, Micheal A, Pandha H, Smith GD, Lewis SJ, Martin R (2016). Blood lipids and prostate cancer: a Mendelian randomization analysis.LID - 10.1002/cam4.695 [doi]. Cancer medicine,
  262. Wang LS, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JD, Cannon-Albright L, Baldwin CT, Zetterberg H, Blennow K, Kukull WA, Faber KM, Schupf N, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Rogaeva E, Lin CF, Dombroski BA, Cantwell LB, Partch A, Valladares O, Hakonarson H, St George-Hyslop P, Green RC, Goate AM, Foroud TM, Carney RM, Larson EB, Behrens TW, Kauwe JS, Haines JL, Farrer LA, Pericak-Vance MA, Mayeux R, Schellenberg GD, Albert MS, Albin RL, Apostolova LG, Arnold SE, Barber R, Barmada M, Barnes LL, Beach TG, Becker JT, Beecham GW, Beekly D, Bennett DA, Bigio EH, Bird TD, Blacker D, Boeve BF, Bowen JD, Boxer A, Burke JR, Buxbaum JD, Cairns NJ, Cao C, Carlson CS, Carroll SL, Chui HC, Clark DG, Cribbs DH, Crocco EA, DeCarli C, DeKosky ST, Demirci FY, Dick M, Dickson DW, Duara R, Ertekin-Taner N, Fallon KB, Farlow MR, Ferris S, Frosch MP, Galasko DR, Ganguli M, Gearing M, Geschwind DH, Ghetti B, Gilbert JR, Glass JD, Graff-Radford NR, Growdon JH, Hamilton RL, Hamilton-Nelson KL, Harrell LE, Head E, Honig LS, Hulette CM, Hyman BT, Jarvik GP, Jicha GA, Jin LW, Jun G, Jun G, Kamboh MI, Karydas A, Kaye JA, Kim R, Koo EH, Kowall NW, Kramer JH, LaFerla FM, Lah JJ, Leverenz JB, Levey AI, Li G, Lieberman AP, Lopez OL, Lunetta KL, Lyketsos CG, Mack WJ, Marson DC, Martin ER, Martiniuk F, Mash DC, Masliah E, McCormick WC, McCurry SM, McDavid AN, McKee AC, Mesulam WM, Miller BL, Miller CA, Miller JW, Montine TJ, Morris JC, Murrell JR, Olichney JM, Parisi JE, Perry W, Peskind E, Petersen RC, Pierce A, Poon WW, Potter H, Quinn JF, Raj A, Raskind M, Reiman EM, Reisberg B, Reitz C, Ringman JM, Roberson ED, Rosen HJ, Rosenberg RN, Sano M, Saykin AJ, Schneider JA, Schneider LS, Seeley WW, Smith AG, Sonnen JA, Spina S, Stern RA, Tanzi RE, Thornton-Wells TA, Trojanowski JQ, Troncoso JC, Tsuang DW, Van Deerlin VM, Van Eldik LJ, Vardarajan BN, Vinters HV, Vonsattel JP, Weintraub S, Welsh-Bohmer KA, Williamson J, Wishnek S, Woltjer RL, Wright CB, Younkin SG, Yu CE, Yu (2015). Rarity of the Alzheimer disease-protective APP A673T variant in the United States. JAMA neurology, 72(2), 209-16.
  263. Tashjian RZ, Farnham JM, Granger EK, Teerlink CC, Cannon-Albright L (2016). Evidence for an Environmental and Inherited Predisposition Contributing to the Risk for Global Tendinopathies or Compression Neuropathies in Patients With Rotator Cuff Tears. Orthopaedic journal of sports medicine, 4(4), 2325967116642173.
  264. Agarwal N, Hahn AW, Gill DM, Farnham JM, Poole AI, Cannon-Albright (2017). Independent Validation of Effect of HSD3B1 Genotype on Response to Androgen-Deprivation Therapy in Prostate Cancer. JAMA oncology, 3(6), 856-857.
  265. Samadder NJ, Smith KR, Wong J, Thomas A, Hanson H, Boucher K, Kopituch C, Cannon-Albright LA, Burt RW, Curtin (2017). Cancer Risk in Families Fulfilling the Amsterdam Criteria for Lynch Syndrome. JAMA oncology, 3(12), 1697-1701.
  266. Savica R, Cannon-Albright LA, Pulst (2016). Familial aggregation of Parkinson disease in Utah: A population-based analysis using death certificates. Neurology. Genetics, 2(2), e65.
  267. Cannon LA, Bishop DT, Skolnick M (1986). Segregation and linkage analysis of breast cancer in the Dutch and Utah families. 1, 43-8.
  268. Bishop DT, Cannon LA, Chamberlin AR, Skolnick MH (1986). Strategies for efficient linkage analysis: example of Huntington's disease pedigrees. Suppl.(1), 217-22.
  269. King MC, Cannon LA, Bailey-Wilson JE (1986). Genetic analysis of human breast cancer: Literature review and description of family data in workshop. Suppl 1, 3-13.
  270. Bailey-Wilson JE, Cannon LA, King MC (1986). Genetic analysis of human breast cancer: A synthesis of contributions to GAW IV. 1, 15-35.

Review

  1. Cannon-Albright LA, Bishop DT, Goldgar C, Skolnick MH (1991). Genetic predisposition to cancer. [Review]. Important Adv Oncol, 39-55.
  2. Cannon-Albright LA, Kamb A, Skolnick M (1996). A review of inherited predisposition to melanoma. [Review]. Semin Oncol, 23, (6), 667-72.

Book Chapter

  1. Neuhausen SL, Skolnick MH, Cannon-Albright LA (1997). Familial prostate cancer studies in Utah. In Semin Oncol (79, pp. 15-20). London: British Journal of Urology.
  2. Burt RW, Dowdle M, Cannon LA, Bishop DT, Lee RG, Skolnick (1984). The colonic adenomatous polyp as a marker for inherited colon cancer. 29, 395-402.
  3. Cannon LA, Skolnick MH, Bishop D (1985). Restriction fragment length polymorphisms and cancer. 248-251.
  4. Burt RW, Bishop DT, Lee RG, Cannon-Albright LA, Skolnick M (1988). Inheritance of colonic adenomatous polyps and colorectal cancer. 189-194.
  5. Burt RW, Cannon-Albright LA, Bishop DT, Skolnick M (1989). Inheritance of susceptibility to colonic adenomatous polyps. 249-251.
  6. Bishop DT, Cannon-Albright LA, Burt RW, Skolnick M (1990). Pedigree analysis of susceptibility to colonic adenomas. 423-430.
  7. Bishop DT, Cannon-Albright LA, Burt RW, Skolnick M (1990). The inheritance of susceptibility to polyps. 39-45.
  8. Skolnick MH, Cannon-Albright L (1996). Penetrance, expressivity, and heterogeneity of melanoma susceptibility: A case study of dominant cancer susceptibility genes. 16,
  9. Singh R, Eeles RA, Cannon-Albright LA, Isaacs (2004). Familial prostate cancer and its management. 339-351.
  10. Cannon-Albright LA, Skolnick M (1996). The genetics of familial breast cancer. 23, 667-672.
  11. Cannon-Albright LA, Bishop DT, Goldgar DE, Skolnick M (1991). Genetic epidemiology of cancer and predisposing lesions. 57-65.
  12. Bishop DT, Cannon-Albright LA, Skolnick M (1991). Linkage mapping of cancer susceptibility genes. 36-48.
  13. Cannon-Albright LA, Bishop DT, Goldgar C, Skolnick M (1991). Genetic predisposition to cancer. 39-55.
  14. Lewis CM, Goldgar DE, Cannon-Albright LA, Skolnick M (1993). Genetic analysis of cancer and precursor lesions. 69-77.
  15. Eeles RA, Cannon-Albright L (1996). Familial prostate cancer and its management. 320-330.
  16. Goldgar DE, Steel L, Neuhausen S, Lewis CM, Cannon-Albright L, Skolnick (1996). Breast and ovarian Cancer in Utah kindreds with three BRCA1 mutations. 49-59.
  17. Burt RW, Cannon-Albright LA, Bishop DT, Samowitz WS, DiSario JA, Skolnick M (1993). Familial factors in sporadic adenomas and colorectal cancer. 10, 688-694.
  18. Goldgar DE, Rowe K, Lewis CM, McDonald M, Gholami K, Cannon-Albright LA, Skolnick (1994). Genetic Epidemiology of familial ovarian cancer in Utah. 13-21.
  19. Neuhausen SL, Skolnick MH, Cannon-Albright L (1998). Genetic susceptibility to prostate cancer. 11-19.
  20. Neuhausen SL, Cannon-Albright L (2000). Progress in the identification of prostate cancer genes. 55-64.

Conference Proceedings

  1. Cannon-Albright L (2006). Computerized genealogies linked to medical histories for research and clinical care--a national view. (2006), 1161-2.
  2. Krikov S, Price R, Allen K, Cannon-Albright L, Facelli J (2008). Enabling GeneHunter as a Grid Service: A Case Study for Implementing Analytical Services for Biomedical Grids. 1014.

Letter

  1. Camp NJ, Werner TL, Cannon-Albright LA (2008). Response to Lynch et al 'Familial Myeloma' [Letter to the editor]. N Engl J Med, 359(16), 1734-5.

Abstract

  1. Cannon-Albright L (2006). Evidence for a heritable component to Chronic Fatigue Syndrome. 25th Annual American Pain Society Mtg, 2006. The journal of pain, 7(4), Supple2, PS105.
  2. Krikov S, Price RC, Allen-Brady K, Cannon-Albright L, Facelli J (2008). Enabling GeneHunter as a grid service: a case study for implementing analytical services for biomedical grids. AMIA ... Annual Symposium proceedings. AMIA Symposium, 1014.
  3. Farnham J, Leachman S, Camp NJ, Cannon-Albright L (2008). Genome-wide case control association study for familial Melanoma identifies 2 significant associations.
  4. Teerlink C, Camp NJ, Cannon-Albright L (2006). Genome-wide linkage analysis for asthma predisposition loci in extended Utah pedigrees.
  5. Cannon-Albright LA, Farnham JM, Camp N (2006). Localization of a Prostate Cancer Predisposition Gene to a 416,515 bp Region on Chromosome Xq28 in Utah High-Risk Pedigrees.
  6. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright L (2006). Genetic susceptibility of Prostate Cancer: Genome-wide screen of men with "non-aggressive" disease.
  7. Camp NJ, Farnham JM, Cannon-Albright L (2006). Localization of a Prostate Cancer Predisposition Gene to an 880 kilobase region on 22q12.2 in Utah High-Risk Pedigrees.
  8. Allen-Brady K, Farnham JM, Camp NJ, Ostrander EA, Karlins E, Cannon-Albright L (2006). BRCA2 mutations in Utah high-risk prostate cancer pedigrees.
  9. Allen-Brady K, Cannon-Albright LA (2006). Early age-at-diagnosis is a characteristic of familial lobular breast carcinoma.
  10. Teerlink C, Cannon-Albright LA (2006). A genealogical assessment of heritable predisposition to asthma mortality.
  11. Norton PA, Nygaard I, Cannon-Albright L (2007). The heritability of pelvic organ prolapse.
  12. Christensen GB, Farnham J, Camp, Cannon-Albright L (2008). Combined Genome-wide Linkage and Association Analysis of extended Utah prostate cancer pedigrees identifies significance at 8q12.
  13. Allen-Brady K, Norton PA Farnham J, Cannon-Albright L (2008). Significant Linkage Evidence for a Pelvic Floor Predisposition Gene on Chromosome 9. Voted "Best non-clinical research presentation Award" for the 38th Annual International Continence Society Meeting, Egypt, Cairo,Oct 20-24, 2009.
  14. Cannon-Albright LA, Farnham JM, Camp N (2005). Using a Utah pseudo isolate population to identify predisposition genes for prostate cancer.
  15. Patel A, Spiker W, Daubs M, Brodke D, Cannon-Albright L (2009). Evidence of an Inherited Predisposition to the Development of Lumbar Disk Herniation.
  16. Camp NJ, Werner TL, Cannon-Albright L (2007). Multiple Myeloma, Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma, Evidence for Overlapping Genetic Etiologies.
  17. Camp NJ, Farnham JM, Cannon-Albright L (2007). Strong Evidence for a Genetic Component to Multiple Myeloma and Pleiotrophy with other Hematologic Malignancies.
  18. Randall RL, Lessnick SL, Kerber R, Virshup D, Coffin CM, Chen LL, Cannon-Albright L (2007). Familial Clustering of Ewing's Sarcoma Observed in a Population-based Resource.
  19. Randall RL, Lessnick SL, Kerber R, Coffine CM, Scaife C, Andbacka R, Cannon-Albright L (2007). A heritable contribution to malignant fibrous sarcomas.
  20. Thomas A, Camp NJ, Farnham JM, Allen-Brady K, Cannon-Albright L (2007). Shared genomic segment analysis.  A novel approach to mapping disease predisposition genes in extended pedigrees using dense single nucleotide polymorphism assays.
  21. Matthews RD, Neumayer LA, Cannon-Albright L (2007). Non-Medullary Thyroid Cancer and Relative Risk of Other Malignancy: An Analysis of the Utah Population Database and Utah Cancer Registry.
  22. Cannon-Albright LA, Nygaard I, Norton (2007). The Heritable Contributions to Lower Urinary Tract Symptoms.
  23. Christensen GB, Camp NJ, and the ICPC (2007). The sumLINK statistic for linkage analysis: An application to the ICPCG pooled linkage resource.
  24. Christensen GB, Camp NJ and the ICPC (2007). Focusing on Linked Pedigrees for Localizing Disease Genes: the sumLINK Statistic Applied to General and Aggressive Prostate Cancer Linkage Data from the ICPCG.
  25. Farnham JM, Camp NJ, Thomas A, Cannon-Albright L (2007). A Method to Calculate the Approximate Density of SNPs Required for Successful Linkage Studies.
  26. Jackson HH, Galsgow RE, Mulvihill SJ, Cannon-Albright L (2007). Familial Risk in Gallbladder Cancer.
  27. Camp NJ, Werner TL, Cannon-Albright L (2007). The Familiality of Multiple Myeloma in the Utah Population Database.
  28. Camp NJ, Farnham JM, Cannon-Albright L (2007). Further localization of the 8q24 prostate cancer locus to a 2.0 Mb region using Utah extended pedigrees.σ.
  29. Curtin K, Cox A, Cannon-Albright LA,Camp N (2008). The role of disease-based discovery panels in tSNP selection.
  30. Shephard N, Brock I, Camp NJ, Cannon-Albright LA, Frank B, Burwinke B, Cox (2008). A multi-centre study of CASP8 polymorphisms in breast cancer. 10(suppl 2), P51.
  31. Cox A, Lin W, Elliot G, Rigas SH, Bishop DT, Cannon-Albright LA, Camp NJ, Neal DE, Donovan JL, Hamdy F (2009). An Investigation of the role of the caspase-8 gene in prostate and colon cancer susceptibility using a SNP-tagging approach.
  32. Teerlink CC, Hegewald MJ, Cannon-Albright L (2008). Assessing the risk of asthma in relatives of cases in the Utah population.
  33. Albright FS, Orlando PL, Cannon-Albright L (2006). Evidence for a heritable Component to Death from Influenza in the Utah Population.
  34. Cannon-Albright L (2006). Utah genealogical database.
  35. Cannon-Albright L (2006). International Invited Presentation: Prostate cancer studies in Utah and the 22q locus.
  36. Cannon-Albright L (2006). National Invited Presentations: Genotypes and Phenotypes: Databases and Diagnosis.
  37. Cannon-Albright L (2006). Unique Utah Resources for Cancer Genetics Research (a Genetic Epidemiology Perspective).
  38. Christensen GB, Farnham JM, Camp NJ, Cannon-Albright L (2006). Survey of Excess Familiarity in Prostate Cancer.
  39. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright L (2006). Genome-wide Linkage Analysis for Aggressive Prostate Cancer in Utah High Risk Pedigrees.
  40. Christensen GB, Farnham JM, Camp NJ, Cannon-Albright L (2008). Combined Genome-wide Linkage and Association Analysis of extended Utah prostate cancer pedigrees identifies significance at 8q12.
  41. Tashjian R, Farnham JM, Albright FS, Teerlink CC, Cannon-Albright L (2009). Evidence for an Inherited Predisposition Contributing to the Risk for Rotator Disease; Presentation by Dr. Tashijan.
  42. Parks TN, Hunter LL, Cannon-Albright L (2009). A population-based analysis of familiality in Auditory Processing Disorder.
  43. Norton P, Allen-Brady K, Cannon-Albright (2010). Significant genome-wide association analysis in pelvic organ prolapse.
  44. Krikov S, Price R, Allen-Brady K, Cannon-Albright LA, Facelli J (2008). Enabling GeneHunter as a Grid Service: A Case Study for Implementing Analytical Services for Biomedical Grids.
  45. Cannon-Albright L (2009). Analysis of a Computerized Genealogy Linked to State-wide Cancer Data to Define Risks for Cancer Among Inbred Individuals.
  46. Albright FS, Orlando PL, Pavia A, Cannon-Albright L (2006). Suggestive Evidence for a genetic component for predisposition to death by influenza from a genealogy linked to 100 years of Utah death certificate data.
  47. Norton P, Allen-Brady K, Cannon-Albright L (2010). Genetic Determinants of Stress Urinary Incontinence in Women.
  48. Patel AA, Spiker WR, Daubs M, Brodke DS, Cannon-Albright L (2009). Evidence of an Inherited Predisposition for Cervical Spondylosis with Myelopathy.
  49. Viskochil D, Cannon-Albright LA, Stevenson (2009). Relative Risks for Cancers in the Neurofibromatosis Population in Utah.
  50. Abo R, Cai Z, Lin WY, Graeme G, Rigas SH, Bishop DT, Cannon-Albright LA, Neal DE, Donovan JL, Hamdy FC, Cox A, Camp N (2009). Identification of a Shared CASP8 Haplotype Associated with Multiple Common Cancers.
  51. Patel A, Spiker W, Bordke (2009). Evidence of an Inherited Predisposition to the Development of Lumbar Disk Herniation.
  52. Patel AA, Spiker WR, Daubs M, Brodke DS, Cannon-Albright L (2010). Evidence of an Inherited Predisposition for Cervical Spondylosis with Myelopathy.
  53. Moore HM, Soisson AP, Dodson MK, Rowe KG, Cannon-Albright L (2010). Familial Clustering of Endothermal Cancer in a Well-Defined Population.
  54. Lee J, Hopf HW, Cannon-Albright L (2010). Familial Association with Surgical Site Infection in a Large Population Database.
  55. Majersik JJ, Cannon-Albright L (2010). Evidence for a Heritable Contribution to Death from Ischemic Stroke.
  56. Albright F, Teerlink C, Farnham JM, Backus S, Cannon-Albright L (2009). Reconstituting Genealogical Information from a Multipurpose Data Resource.
  57. Majersik JJ, Cannon-Albright L (2010). Evidence for a Heritable Contribution to Death from Ischemic Stroke.
  58. Wang W, Cannon-Albright LA, Tishler P (2010). Familial Aggregation of Age at Diagnosis of Prostate Cancer. 34, 973.
  59. Cannon-Albright LA, Leachman S (2010). Melanoma Cases with Multiple Independent Primary Melanomas Show the Strongest Evidence for a Heritable Predisposition.
  60. Allen-Brady K, Cannon-Albright L, Baker J, Norton (2011). Population-based Description of Familial Clustering in Overactive Bladder.
  61. Cannon-Albright (2011). Genome-wide Germline Genotypes from Normal Tissue Stored in FFPE Samples.
  62. Norton P, Allen-Brady K, Cannon-Albright L (2010). Genetic Determinants of Stress Urinary Incontinence in Women.
  63. Teerlink CC, Farnham JM, Allen-Brady K, Camp N, Horne B, Cannon-Albright L (2010). Using Publically Available Control Data for GWAS ¿ A Simple Strategy for Genetic Matching.
  64. Patel AA, Spiker WR, Sofianos DA, Daubs M, Brodke DS, Cannon-Albright L (2011). Evidence of an Inherited Predisposition for Cervical Spondylosis with Myelopathy.
  65. Wang W, Cannon-Albright LA, Tishler (2010). Studies on the Familial Aggregation of Age at Diagnosis of Prostate Cancer: The Utah Population Database.
  66. Spiker WR, Patel AA, Brodke DS, Daubs M, Cannon-Albright L (2011). Evidence of an Inherited Predisposition for Spinal Cord Tumors.
  67. Kareus S, Cannon-Albright L (2011). Relative Risk for Melanoma and Lung Cancer in the Parkinson 's Disease Population and Their Relatives Using the Utah Population Data Base.
  68. Kareus S, Cannon-Albright L (2011). Parkinson's Disease and Prostate Cancer: Insights Using the Utah Population Data Base.

Other

  1. Teerlink CC, Cannon-Albright LA, Tashjian RZ (2016). Erratum to "Significant association of full-thickness rotator cuff tears and estrogen-related receptor-ß (ESRRB)" [J Shoulder Elbow Surg 2015;24:e31-e35]. J Shoulder Elbow Surg (25(5), p. 864). United States.
  2. Tashjian RZ, Granger EK, Farnham JM, Cannon-Albright LA, Teerlink CC (2016). Erratum to "Genome-wide association study for rotator cuff tears identifies two significant single-nucleotide polymorphisms" [J Shoulder Elbow Surg 2016;25:174-179]. J Shoulder Elbow Surg (25(10), p. 1731). United States.
  3. Saunders EJ, Dadaev T, Leongamornlert DA, Al Olama AA, Benlloch S, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pasayan N, Khaw KT, Stanford JL, Blot WJ, Thibodeau SN, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Teixeira MR, Pandha H, Govindasami K, Muir K, Easton DF, Eeles RA, Kote-Jarai (2018). Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array. 118(6), e9.
  4. Piepkorn M, Cannon-Albright LA, Meyer LJ, Goldgar DE, Zone JJ, Skolnick M (1994). Genetic predisposition to melanoma. 12(2), 1-4.